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Association with GW

T

his column is the fi rst in my current role
as interim vice provost for health affairs
and dean of GW’s School of Medicine and
Health Sciences (SMHS). I was appointed in December 2010 as the Medical Center embarked on
a complex reorganization. In addition to those administrative changes, this has truly been a remarkable year for SMHS in terms of its faculty recruitments, its medical student and residency matches,
its research productivity, and the enhanced stature
of its academic programs.
This also was a year, however, in which two
GW doctors, important to me in very different
ways, passed away. One of these physicians,
Herbert Weintraub, M.D., was well known to
our SMHS family. The other physician, Leonard
C. Akman, M.D., was best known by his fellow
members of the Class of 1943.
Herb Weintraub was a highly esteemed former
chair of GW’s Department of Anesthesiology.
Although I knew him only in his post-retirement
years, he was part of the generation of nationally recognized academic physicians who came to
GW in the 1970s and built the modern academic
medical center that we know today.

This group included many of Herb’s colleagues:
Burt Epstein (anesthesiology), Allan Weingold
(OB/GYN), Sy Perlin (psychiatry), and many
others who trained thousands of GW residents,
medical students, and health science students.
They also educated and trained many of the current and former leaders at SMHS, including me. I
am profoundly grateful to Herb and the other faculty who led the Medical Center for three decades.
A few days before I left to begin medical school
at GW, my father’s cousin, Leonard Akman,
dropped by my family’s home for a visit. Leonard,
an SMHS alumnus, was a very private man and a
highly regarded cardiologist. So it was a great surprise when he gave me a beautiful new microscope.
Today, medical students learn microscopic
anatomy sitting in front of a computer screen. In
1977, however, we brought our own microscopes
to learn histology, microbiology, and pathology.
That gift was a demonstration of Leonard’s profound, quiet connection to GW.
Through the years, GW colleagues would ask
me about Leonard. He remained private, however,
and while his relationship with my family blossomed, he still had little contact with his classmates. But, thanks to my encouragement, Leonard
returned to GW in 1993 to celebrate his 50th M.D.
class reunion. It was a joyous occasion for him and
gave me further understanding of the crucial role
that GW played in his life.
I doubt that Herb Weintraub and Leonard
Akman knew each other. Yet both their lives
were profoundly inﬂuenced by their association
with GW, and both showed their gratitude with
generous bequests to the school. Herb’s gift will
support residency training in the Department of
Anesthesiology. Leonard’s gift will support education and scholarships in the name of his parents.
My leadership role at SMHS is inﬂuenced by
Herb Weintraub and his generation of physicians,
and by Leonard Akman’s love of his alma mater.
Sincerely,

JeFFreY s. aKman, m.d. ’81, G.m.e. ’85
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Henry J. Kaminski, M.D.

Neurology Welcomes
New Chair Kaminski
Following an extensive national
search, GW’s School of Medicine and
Health Sciences (SMHS) has selected
Henry J. Kaminski, M.D., as the Meta
Amalia Neumann Professor and Chair
Kaminski most recently served as
professor and chair of the Department
of Neurology and Psychiatry and
director of the Clinical Research

More than 180 students were welcomed into the GW medical community at the

Unit at Saint Louis University, and

annual White Coat and Honor Code Ceremony in Lisner Auditorium Aug. 20.

officially joined the GW faculty on

Students received their first white medical coats, signifying the start of their

Sept. 1, 2011.

journey toward careers in the medical profession. They also recited the GW

“Dr. Kaminski is an internation-

School of Medicine and Health Sciences (SMHS) Oath and signed the GW

ally recognized expert in care of

Honor Code pledge.

patients with myasthenia gravis, and

GW’s class of 2015 — the most competitive in the history of SMHS — repre-

his research has received continuous

sents 29 states, the District of Columbia, and Canada. Among its ranks are 23

sponsorship by the National Institutes

emergency medical technicians, a professional lacrosse player, and a Fulbright

of Health since 1993,” said Jeffrey S.

Award winner.

Akman, M.D. ’81, G.M.E. ’85, interim

Edward O’Neil Jr., M.D. ’87, associate professor of emergency medicine at
Tufts University, gave the keynote address.
O’Neil — who founded Omni Med, a Massachusetts-based nonprofit that
trains health providers and community workers and runs health service programs in Uganda, Belize, Guyana, and Kenya — described the “sense of

vice provost for Health Affairs and
dean of SMHS. “I have every confidence that he will bring strong leadership to the department.”
Kaminski’s studies are focused on

wonder” he felt during his first days as a physician and his health care work in

understanding the biology of the extra-

some of the poorest regions in the world. He told the first-year medical students

ocular muscle and the pathogenesis

that physicians get to “perform miracles.

of myasthenia gravis. His laboratory is

“As you start on this wonderful career of becoming physicians, I would ask

currently working to develop inhibitor-

that you find a passion to make a difference somewhere in your lives,” he said,

based treatments for myasthenia gravis

adding, “engage in the problems of the world, because they are many.”

and other neuromuscular disorders.

The annual event is sponsored by the GW Medical Alumni Association and

Kaminski replaced John J. Kelly,

the White Coat Initiative, who generously donate the funds to purchase each

M.D., who had served as professor

new class’s white coats. This year’s celebration was co-chaired by second-year

and chair of the department with dis-

medical students Todd Spock, DiAnne Davis, and Sarah Todd. n

tinction for the last 20 years. n
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White Coat Event Signals
the Start of Something Big

of the Department of Neurology.

Since the launch of TobaccoFreeRx, Jha has emerged
as an accessible resource for other activists across
the country. He has helped an Oregon county health
department pass an ordinance prohibiting tobacco sales
in pharmacies and an anonymous pharmacist write a
tobacco-free policy for a pharmacy chain.
Locally, Jha has presented his case to the D.C. Board
of Pharmacy and initiated discussions with the D.C.
Department of Health and the dean of the Howard University
School of Pharmacy.
Jha says that legislation is not the only route to success. Most importantly, he hopes his efforts will strike
other people’s ridiculous nerves. “I hope this is just a
moment in time,” he says, “and maybe 10 or 20 years from
now we’ll look back and say, ‘Boy, isn’t it ridiculous that
pharmacies were still selling cigarettes in 2011?’ ” n

A Prescription for Change

Avon Foundation Supports Patient
Navigation, Breast Cancer Tests

The thought first struck what Vinayak Jha, M.D., assistant

The George Washington University Cancer Institute (GWCI)

professor of Medicine, calls his “ridiculous nerve.”

and the School of Medicine and Health Sciences (SMHS)

Then, it struck his curiosity nerve, which struck his ac-

$400,000 to support patient navigation services and

and amateur community organizer — became committed to

research to develop a new test to assess risk of breast

a cause that, just minutes earlier, he hadn’t known existed.

cancer. Christina Cianflone, director of GWCI’s Division

“When I learned that the sale of tobacco had been

of Cancer Prevention and Community Health, accepted

banned in pharmacies in San Francisco and Boston, I

a check on May 1, during the closing ceremony for the

wondered what the status was in D.C.,” he recalls. “It didn’t

Washington, D.C., Avon Walk for Breast Cancer.

take long to figure out that there is no status in Wash-

“The support of the Avon Foundation allows us to

ington, D.C. In fact, hardly anyone had even heard of the

continue to provide access to screenings and follow-up

issue.” And so he decided it was a cause worth fighting for.

care for women in the most vulnerable populations and

TobaccoFreeRx, Jha’s resulting campaign, seeks to
eliminate the sale of tobacco in Washington, D.C., pharmacies (including retail stores that contain pharmacies)

expand our patient navigation services in the GW Breast
Imaging Center,” said Cianflone.
GWCI received a $250,000 award to support three

through a combination of grassroots advocacy, endorse-

patient navigation and education programs — a

ments from professional and government organizations,

partnership with the Capital Breast Care Center to help

and tactics of “embarrassment and exposé,” he admits.

underserved women receive screening and follow-up

“What characterizes a place that calls itself a pharmacy
© Stock IlluStratIon Source

received a pair of grants from the Avon Foundation totaling

tion nerve. Suddenly, Jha — a pulmonary disease specialist

care; patient navigation services offered by the GW Breast

is having a health care provider who is licensed by the

Imaging and Intervention Center, and GWCI’s m-health

Department of Health, whose sworn goal — and personal

Breast Self-Exam Reminder Text Message Program.

philosophy — is to keep people healthy,” Jha reasons.

For the third consecutive year, SMHS received a

“Unlike a convenience store or gas station, these places

$150,000 Avon grant to support research led by Patricia

are operating as health care enterprises, so they shouldn’t

Berg, Ph.D., professor of Biochemistry and Molecular

sell the same products that will cause the diseases for

Biology. The project seeks to develop a new test to assess

which you need the medications.”

risk of breast cancer. n
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tigators were able to compare their
reaction to parasite infestation to that
of the normal, wild-type mice.
At various stages after infection,
blood from the portal circulatory
system of the liver was analyzed for
worms and parasite eggs. “At the
12th week of infection, we found that
the wild-type mice had severe granulomatous lesions in the liver,” says
lead author Sujit Nair, Ph.D., assistant
research professor in SMHS’s Department of Biochemistry and Molecular
Biology. “Their worm count was very
high. In the mice that did not have
the gene, however, there were neither
worms nor eggs that we could collect
from the portal perfusion.”
From these results, the researchers
concluded that absence of the MTA1
gene does not compromise the mice’s
susceptibility to the parasite infection,
but it does limit the survival or maturation of schistosomes in the host, and

Schistosome Parasites Linked
to Deadly Bladder Cancer

possibly egg release and deposition.

Researchers at GW’s School of Medicine and Health Sciences (SMHS) have

explains that expression of MTA1,

identified a gene that enables the parasite Schistosoma haematobium to es-

a nuclear protein, regulates the

tablish a foothold in its human host, which ultimately may lead to a devastating

expression of inflammatory cytokines

form of bladder cancer.

that are produced by Th1 and Th2

Schistosomes, or helminth worms, are waterborne parasites that can cause

Senior author Rakesh Kumar,
Ph.D., professor and Catharine
Birch & William McCormick Chair of
Biochemistry and Molecular Biology,

cells of the immune response. By

chronic inflammation and fibrosis in the liver, symptoms that may migrate to the

increasing the expression of MTA1

bladder, causing inflammation, granulomas, and eventually, bladder cancer. The

in the wild-type mice, the parasite

worm is responsible for two-thirds of the world’s 200 million to 400 million cases

“hijacks” the gene, “which in

of human schistosomiasis, resulting in an estimated 280,000 deaths per year.

turn allows it to up-regulate pro-

In the July issue of the journal Hepatology, researchers from SMHS describe

inflammatory cytokines, and these

how they demonstrated the role of the metastasis-associated protein-1 (MTA1)

pro-inflammatory cytokines in turn

gene in the proliferation of schistosomes. They infected two strains of mice with

will provide a favorable atmosphere

schistosome cercariae, a larval stage of the parasite. One group of mice, wild-

for the pathogens to grow and cause

type, had an intact MTA1 gene in their DNA. The other mice, MTA1-/-, lacked

a persistent inflammation,” he says.

that gene, but were otherwise genetically normal. MTA1 is a crucial gene that

“It’s the persistent inflammation

controls the process of chromatin remodeling of cytokines, including those

over time that we believe can lead to

responsible for inflammation. By using the mice that lacked the gene, inves-

cancer.” n
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GW Cheney Institute Donates
100th Life-Saving Automated
External Defibrillator
Sudden cardiac arrest (SCA) is the nation’s leading cause
of death, claiming more lives each year than breast cancer,
lung cancer, and HIV/AIDS combined. Starting with an
electrical disruption in the heart’s normal rhythm, SCA leaves
victims with weak, fluttering heartbeats. Blood stops flowing
properly, depriving the body of precious oxygen. Brain
injury will ensue unless blood flow is restored within five

Eliminating Breast
Cancer Disparities
Debbie Wasserman Schultz is often told that she is lucky
to be alive. The 45-year-old congresswoman from Florida
and the new chair of the Democratic National Committee
overcame a particularly lethal type of breast cancer, but
she says her survival has more to do with awareness and
education than luck.
As the keynote speaker at the “Eliminating Breast
Cancer Health Disparities: Communicating to At-Risk
Populations” symposium, Wasserman Schultz used her
story to underscore the importance of both knowledge
and access to care in the fight against breast cancer
— a disease whose prevalence and severity varies with
ethnic background. The event, hosted by GW’s School
of Medicine and Health Sciences, the GW Medical Faculty Associates, the Avon Foundation for Women, and
Friends of Cancer Research, explored how cancer centers, community health centers, advocacy organizations,
and government agencies can improve communication
with underserved populations in order to eliminate breast
cancer disparities.

PhotograPhy by JeSSIca Mcconnell burt

The symposium featured a panel of local and national

minutes. According to the American Heart Association, for
each minute of delay before normal blood flow is restored,
the likelihood of survival decreases by 10 percent. Overall,
survival rates for SCA range from a high of 16.3 percent to a
low of 3 percent in some regions of the country.
District of Columbia Public Library System patrons and
employees now stand a better chance of beating those
odds, thanks to The George Washington University Cheney
Cardiovascular Institute’s “ReStart DC” program, which
donated automated external defibrillators (AEDs) to all
25 library locations. The AEDs, presented in May at the
library system’s Chevy Chase branch, marked the 100th
community donation since the ReStart DC AED program
was launched in 2009.
The Cheney institute launched the program with the
goal of increasing survival rates from SCA in the District
of Columbia. So far, it has donated AEDs to nonprofit
organizations, community centers, houses of worship,
and other organizations. ReStart DC also provides AED
training, medical oversight, and direction for organizations
serving low-income communities throughout the city.
Now commonplace in public settings, such as airports,
shopping malls, schools, and office buildings, the easyto-use devices are safe to operate and proven to save lives
when seconds count the most.
“As great as our cardiac program is, patients often

breast cancer advocates led by Rachel Brem, M.D.,

reach us too late,” says Jonathan Reiner, M.D., professor of

director of GW’s Breast Imaging and Intervention Center,

Medicine and director of The George Washington University

who emphasized that a multifaceted solution is needed

Hospital’s Cardiac Catheterization lab. “By deploying AEDs

to address breast cancer disparities that arise from both

and training people in CPR, we are enlisting the entire

biological differences and societal barriers to care. Sug-

community to help in our efforts to improve survival rates

gestions included boosting minority enrollment in clinical

by speeding the response to cardiac emergencies.”

trials and increasing the use of patient navigators.
“If there is one message here, it’s that there are multiple

AED donations to the DC Public Library system were
made possible through the efforts of volunteers with the

messages,” concluded Brem. “We have to work collabora-

Friends of the DC Library and Mended Hearts, which

tively with research, with education, with community health

raised a portion of the funding, as well as support from

services in order to really optimize the care for all women.” n

Philips Healthcare. n
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their unborn children,” Stagnaro-Green concluded. n

Education and professor of Medicine and of Obstetrics

NCI-NIH Award Helps Researchers
Battle Parasite-Induced Cancer

and Gynecology at the GW School of Medicine and Health

Researchers from GW’s School of Medicine and Health

Sciences (SMHS), recently announced new guidelines for

Sciences (SMHS) received a $2.5-million grant from the

the diagnosis and management of thyroid disease during

National Cancer Institute of the National Institutes of Health

pregnancy and the postpartum period. The guidelines,

to develop a technique for detecting a deadly form of bile

published in the July edition of the journal Thyroid (v. 21,

duct cancer caused by parasites. The R01 award supports

n. 10), are the culmination of nearly two years of compre-

a team of SMHS researchers developing proteomic bio-

hensive analysis of current practice, academic literature,

markers for Cholangiocarcinoma (CCA), a cancer caused

An American Thyroid Association (ATA) task force led by
Alex Stagnaro-Green, M.D., senior associate dean for

and emerging research into the treatment of thyroid dis-

by the liver fluke Opisthorchis viverrini. The foodborne

ease and its effects on pregnancy and postpartum.

parasite currently infects more than 40 million people, pri-

During pregnancy, the thyroid — an endocrine gland

marily in the Southeast Asian countries of Thailand, Laos,

that regulates metabolism and influences critical body

and Cambodia, where fish infested with the parasite are a

functions such as heart rate — produces up to 50 per-

staple of the local diet.

cent more hormones than normal. “In essence,” explains

“CCA is a serious cancer with a very poor prognosis,”

Stagnaro-Green in the task force report, “pregnancy is a

says Paul Brindley, Ph.D., a tropical disease specialist and

stress test for the thyroid, resulting in hypothyroidism in

professor in SMHS’s Department of Microbiology, Immu-

women with limited thyroidal reserve or iodine deficiency.”

nology, and Tropical Medicine (MITM). Because patients

Over the years, a growing body of research — much

often have nonspecific symptoms, such as abdominal pain

of which has been conducted by Stagnaro-Green him-

and fatigue, the cancer “is usually not diagnosed until it’s

self — has indicated that even slightly too much or too

well advanced, and sadly, people generally don’t live very

little thyroid function during pregnancy can raise the

long after it’s diagnosed,” he adds.

risk of spontaneous miscarriage, preterm delivery, and a

The GW research team, led by Brindley and Jeffrey M.

decreased IQ in the unborn child. But until now, this and

Bethony, Ph.D., associate professor in MITM, will use a

other related research has not been translated into guide-

quantitative proteomics approach to scan tumor tissues

lines for clinical practice.

and matched plasma from bile duct cancer patients to

6 GWUMC.EDU • F A L L 2 0 1 1
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New Guidelines for Thyroid Disease
During Pregnancy and Postpartum

Stagnaro-Green’s international team of experts
included thyroidologists, obstetricians, and midwives in
order to develop guidelines that would be comprehensive and widely adoptable. Together, they developed 73
recommendations in nine areas, which are thyroid function
tests, hypothyroidism, thyrotoxicosis, iodine, anti-thyroid
antibodies and miscarriage/preterm delivery, thyroid nodules and cancer, postpartum thyroiditis, screening during
pregnancy, and areas for future research.
Each guideline was reviewed on the basis of the varying
levels of conclusive evidence; thus, the task force rated the
strength of each according to the United States Preventive Services Task Force Guidelines. Of the 73, only 18
received the highest recommendation level — an indication
that there is still much to learn about the role of the thyroid
during pregnancy and the postpartum period.
“It is our hope that the present guidelines provide useful
information to clinicians and help achieve our ultimate goal
of the highest quality clinical care for pregnant women and

F rom the CeNter

a very poor prognosis

Stem Cells Take Cues
from Fluid in the Brain

because patients often have

Circulating in the fluid surrounding the brain is a little-known protein that,

nonspecific symptoms and

of cells in the developing cortex. The discovery, made by a multi-institutional re-

the cancer is usually not

Zappaterra, and Christopher Walsh and researchers from GW’s School of Medi-

diagnosed until it’s well

journal Neuron.

advanced . . .

director of the GW Institute for Neuroscience at SMHS, and an author of the

CCA is a serious cancer with

researchers have discovered, plays a crucial role in the growth and position
search team at Children’s Hospital Boston led by Maria Lehtinen, Mauro
cine and Health Sciences (SMHS), was published in the March 10 edition of the
“This study is a game changer,” says Anthony-Samuel LaMantia, Ph.D.,
paper along with Thomas Maynard, Ph.D., associate professor of Pharmacology
and Physiology at GW. “It’s remarkable that signals are coming from the cere-

identify potential biomarkers near the
disease site. The researchers will then

brospinal fluid — it makes sense, but no one really thought about it in this way.”
The cerebrospinal fluid was originally thought to be simply a colorless salt

verify these markers by examining

solution that served to cushion the brain and help maintain ionic balance,

plasma from members of the study

but when scientists looked more closely at it, they discovered something

who are at risk for the cancer but are

unexpected. The fluid contained high levels of a particular protein that signals

currently healthy.

brain cells to multiply at a critical moment in embryonic brain development.

The GW team will partner with
Jason Mulvenna and Alexander
Loukas from the Queensland Tropical
Health Alliance, James Cook University, in Cairns, Australia, and Banchob
Sripa, head of the Tropical Disease

Researchers identified an insulin-like protein (Igf2) in the cerebrospinal fluid
of mouse embryos that is known to prompt stem cells to multiply and differentiate. When the researchers blocked Igf2, stem cells in the brain stopped
making brain cells, and when the team placed brain stem cells in a dish filled
with Igf2-rich cerebrospinal fluid, the cells proliferated rapidly. “This was clearly

of developing liver fluke-induced bile

the environment the stem cells needed to be happy,” LaMantia explains.
Brain cells in the cortex — the outermost layer of the brain responsible for
cognition, learning, and memory — multiply and move to their appropriate
position between the second and third trimesters of development. But until
now, researchers have had little luck finding the molecular signals that direct
the process.
Brain cell proliferation, however, is a good thing only when the time is right.
Unrestrained growth leads to tumors. According to this report, Igf2 knows when
to activate thanks to proteins in the long glial cells that stretch from the inner
part of the brain to its outer layer. These cells form early in development, and
serve to guide younger brain cells on the way to their appropriate positions
during development.
If one of the steps in this pathway goes awry, Igf2 could be activated at the
wrong time, causing uncontrolled proliferation. Indeed, brain cancer patients
who have the worst prognoses appear to have the highest levels of Igf2.
The fact that vital signals are sent from cerebrospinal fluid, however, could
be good news for patients suffering from brain cancer. “It’s difficult to deliver a
drug that will influence a specific spot within the brain tissue,” says LaMantia.
Instead, clinicians might one day infuse brain fluid with medicine — possibly
one that blocks the signals from Igf2 telling cells to proliferate. “The possibilities for using the fluid as an efficient mechanism to deliver small molecule

duct cancer. n

drugs are endless,” he says. n

Research Laboratory, Department
of Pathology, Faculty of Medicine
at Khon Kaen University. Although
parasite-induced cancer is a serious
problem throughout Southeast Asia
and southern China, its epicenter is
near Khon Kaen University in northeastern Thailand.
Brindley and Bethony began the
CCA cohort study as part of an International Collaborations in Infectious
Diseases Research grant awarded by
the National Institute of Allergy and
Infectious Diseases. Researchers
recruited residents from the endemic
areas along the Chi River basin in
northeastern Thailand, and they are
currently following more than 1,000
individuals identified to be at high risk
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Anton SidAwy, M.d., M.P.H., SHAreS HiS ViSion for
tHe future of Surgery At gw

W

by Adrian Larssen

hen Brian Blades, M.D., was appointed
chair of Surgery in 1946, there was no way
he could have imagined what his department would look like today. If he saw it
now, he might compare the hospital’s
computer-controlled robots — which frequently replace traditional scalpels — to visions possible only in science fiction
novels. Surgeons, he might marvel, are no longer limited by
the flexibility of their wrists or the acuity of their vision as
they perform complex procedures.
Blades couldn’t know what the future would hold, but he
did have a vision: One that built a foundation that made all of
today’s accomplishments possible, says Anton Sidawy, M.D.,
M.P.H. ’99, who began his tenure as chair of the department
in December 2010.
Now, Sidawy, an internationally renowned vascular
surgeon, former chief of surgical services at the D.C. Veterans

8 GWUMC.EDU • F A L L 2 0 1 1

with an excellent group of surgeons at this stage of my career.” n

PhotograPhy by holger thoSS

A Legacy of Excellence

Affairs Medical Center, immediate past president of the
Society for Vascular Surgery, and current editor-in-chief of
the Journal of Vascular Surgery, has his own vision: “to take
what is excellent and improve upon it.”
Sidawy, who has served on the GW faculty for 25 years,
aims to expand and reorganize the department, adding surgical services, programs, and divisions, as well as a greater
number of specialized subspecialties. “When you come to
GW as a patient,” he explains, “not only will you be treated
by a specialist, but you will be treated by a specialist with a
very specific interest in your condition.”
He has started the process by expanding a division he
knows much about: vascular surgery, which was formerly
a two-person operation. Sidawy added four surgeons to the
team with a diverse set of interests, dramatically expanding
the division’s clinical clout and workload. “In a short time,
it has become one of the most comprehensive groups in the
region,” he notes. Most of the new faculty members also
will be conducting research and boosting the department’s
capacity for clinical studies and trials.
In addition, the Division of General Surgery will be
restructured to promote the growth of subspecialties, including
hepato-biliary-pancreatic surgery, bariatric surgery, minimally
invasive surgery, foregut surgery, and trauma. Currently, a
national search is under way for a new director of trauma.
When the position is filled, Sidawy will have increased the
department’s full-time faculty by about 25 percent.
“It’s all really exciting. We are bringing in surgeons who
not only are clinically top-notch, but also have research potential and are excellent educators,” he says.
Sidawy also hopes to build upon the department’s educational endeavors, and recently founded the Division of
Surgical Education, which will incorporate faculty from all
specialties to study and develop new educational paradigms
for students and residents.
Meanwhile, Sidawy remains cognizant of the department’s storied past. He recently renamed the resident teams
(formerly merely numbers) after Blades and other former
chairs, including Paul Adkins, M.D., a renowned thoracic
surgeon; Ralph DePalma, M.D., who strengthened GW’ surgical residents’ research efforts; and Joseph Giordano, M.D.,
the founder of the GW Trauma Center. “This reminds residents and students of the excellent history the department has
had over the years, and provides them and the junior faculty
with a sense of continuity and historical perspective they can
be proud of,” he explains.
And Sidawy feels the same way about his new post. “On a
daily basis, I work with surgeons who want to do the best they
can do for patient care, education, and advancing the science of
surgery,” he says. “I feel quite fortunate and proud to be given
the opportunity to lead this department at GW, and to work

Hair Loss remedy
Linked to Loss of Libido
ASSiStAnt ProfeSSor MicHAel S. irwig, M.d.,
uncoVerS SeriouS ProbleMS witH ProPeciA

PhotograPhy by holger thoSS
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by Thomas Kohout

ccording to the American Academy of Dermatology, roughly 50 million men and as many as
30 million women in the United States experience some form of hereditary hair loss. And
by most accounts, Americans spend more than
$1 billion each year on shampoos, potions, pills, toupees, and
transplants to ward off the effects of hair loss. But how much
is too much to pay for a full head of hair?
A new study by Michael S. Irwig, M.D., and assistant professor of Medicine in the Division of Endocrinology at GW’s
School of Medicine and Health Sciences, who is also director
of the Center for Andrology, suggests that men who take the
hair loss drug finasteride — marketed by Merck under the
trademark Propecia — may be paying a much steeper price
than they expected. In the study, published in the Journal of
Sexual Medicine, Irwig reveals that otherwise healthy men
taking finasteride may experience ongoing sexual side effects
well after they stop using the medication.

That news has attracted global attention; Irwig and his
study have been widely featured in print, broadcast, and
online media, including MSNBC.com, Time.com, and la
Folha, one of Brazil’s largest newspapers. The story was featured on CBS television stations in Chicago, New York, and
Philadelphia, as well as on CBS Radio.
Finasteride inhibits the enzyme that converts testosterone
to dihydrotestosterone, the male hormone associated with
virilization and male pattern baldness. The drug was initially
approved by the U.S. Food and Drug Administration (FDA)
in 1992, under the brand name Proscar, as treatment for an
enlarged prostate. Five years later, the FDA approved finasteride under the name Propecia to treat male pattern baldness.
An endocrinologist by training, Irwig launched the study
after seeing several patients who reported persistent sexual
side effects despite having stopped taking finasteride. He
then found a website featuring posts about persistent sexual
and other problems that adversely affect quality of life, with
entries from more than 1,400 men.
Irwig studied a pool of 71 healthy men ages 21 to 46, who
did not report any psychological issues such as anxiety or
depression before starting finasteride. A staggering 94 percent
of the men said they developed low sexual desire, 92 percent
said they developed decreased arousal, 92 percent reported
developing erectile dysfunction, and 69 percent said they developed problems with orgasm. Most patients used finasteride for
an average of 28 months, but sexual side effects lasted for an
average of 40 months after use was discontinued.
In the study, said Irwig, “we sought to characterize the
types and duration of persistent sexual side effects in otherwise healthy men who took finasteride.” He added that
prior to his research, nobody had really described this effect.
“While finasteride has been associated with reversible adverse
sexual side effects in multiple randomized placebo-controlled
trials, this is the first series to find that symptoms persisted
for at least three months despite stopping finasteride.”
Although all the patients experienced the side effects for
at least three months after they stopped using finasteride,
explained Irwig, “as many as 20 percent said problems persisted for up to five years.”
The exact incidence of persistent sexual dysfunction is
unknown, according to Irwig, because there is no accurate
count of the number of people who have been prescribed
the drug. He recommends that men contemplating the use
of finasteride, whether for baldness or an enlarged prostate,
discuss the potential risk for persistent sexual side effects
with their doctors.
“Many of the men said, ‘Had I known about this beforehand I might have chosen another option,’ ” said Irwig.
“It underscores how important it is for physicians who are
treating male pattern hair loss to discuss the potential risk of
persistent sexual side effects with their patients.” n
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Brian Choi, M.D., assistant professor of Medicine in the Division of Cardiology, with an iPad displaying an echocardiogram.

Practicing Smarter with m-health Technology
The world is growing smaller as the cost of mobile technology plummets and
more high-powered smartphones reach the hands of eager new customers.
Many observers expect global mobile communications penetration to reach
100 percent within the next five years, and by 2016 there will hardly be a spot
on the planet where one can’t place a call using a cell phone.
Although the surge of mobile technologies is
good news for telecommunications companies, it’s even better news for those in need
of health care when access is a problem.
Through m-health, or the rapidly evolving
practice of medicine and public health via
mobile communications devices, the face of
patient care is changing as studies and pilot
10 GWUMC.EDU • F A L L 2 0 1 1

programs test the efficacy of the handheld
devices for use in medicine.
Members of GW’s School of Medicine
and Health Sciences (SMHS) are leading the
way in these endeavors, exploring m-health
technology for use in a variety of areas
including critical cardiac diagnoses, medication adherence, and diabetes management.

SmArtphoneS, SmArt heArt
One of these studies, led by Brian Choi, M.D., assistant
professor of Medicine in the Division of Cardiology, recently
confirmed that echocardiogram images taken with mobile
cardiac ultrasound devices are as readable and accurate on
smartphones and tablet computers as they are on a conventional workstation. These findings mean expert echocardiographers can receive, review, and interpret high-quality images
transmitted directly from the field using handheld ultrasound
devices, making critical diagnoses more accessible and patient
care more efficient.
The study began in August 2010, when Cindy Tracy, M.D.,
professor of Medicine and director of Cardiac Services at GW
Hospital, led a medical mission to Honduras in a particularly
inaccessible mountainous region of Central America. Because
of the remote location and a limited ability to bring diagnostic
equipment, Choi suggested the team use a handheld ultrasound device called a GE Vscan.
“The GE Vscan was perfect for this kind of application
because it’s so portable,” Choi recalls. The Cheney Cardiovascular Institute took Choi’s advice and purchased the device for
the trip, allowing Tracy’s team to collect diagnostic images.
“I was interested in looking at those images to determine if
reading them off of a smartphone was as accurate as reading
them on a traditional workstation.”
Working with third-party commercial software developer
mVisum, which created the HIPAA-compliant smartphone
application, Choi sent echocardiographs from 89 patients for
analysis by two experts in the United States, who reviewed
them on conventional workstations. Afterward, the images
were also sent to echocardiographers who reviewed them
using a smartphone. Choi then compared the results. The
smartphone diagnosis was considered accurate only if an
abnormal finding matched at the same level of severity as the
interpretation made using the conventional workstation.
“The correlation between the two was very high,” says
Choi. “We did a statistical test that showed the diagnoses
matched 90 percent of the time. Now that we know reading
echoes from a smartphone is nearly as accurate as reading
them from a workstation, the key is figuring out how to best
incorporate this technology into a standard of care.”
The devices’ implications for medical missions to underserved locations are clear, but, Choi argues, there are practical applications for the United States as well. “Not only can
there be a similar interaction between rural sites and tertiary
referral care centers,” he says, “but also, these devices could
fill an important gap in urgent and off-hours interpretations
when experts may not be immediately available.”

mediCAtion AdherenCe: phoning it in
GW physicians are also exploring how cell phones might
improve medication adherence among patients with hypertension, a disease estimated to affect more than 65 million adults

in the United States. Following prescriptions is particularly
important for blood pressure patients because poor adherence
to medications can result in serious complications, such as
kidney disease. What’s more, many patients who suffer from
high blood pressure also have other conditions that could
result in a drug regimen of up to 10 pills a day.
With a grant from Qualcomm’s Wireless Reach initiative,
and contributions from One Economy, Cricket Communications, and VOCEL, GW researchers led a seven-month
study to determine whether 3G wireless-enabled cell phones
with a mobile medication reminder application could engage
patients, improve health outcomes, and reduce health costs.
They nicknamed the device the Pill Phone.
“High blood pressure and diabetes are the leading causes of
kidney disease, and Washington, D.C., has some of the highest
rates of end-stage kidney disease in the nation,” says Richard
Katz, M.D., Bloedorn Professor of Medicine and director of
the Division of Cardiology. “The Pill Phone Research Study
offers a model for disease self-management that can be
applied to at-risk communities.”
Patients received 3G wireless handsets preloaded with
the Pill Phone application. They received medication dosage
reminders, tracked dosage records, images of the pills, and
real-time information about potential drug side effects and
interactions. Health care providers were able to remotely
monitor patient adherence through a secure website.

moBiLe teChnoLogY And mAnAging diABeteS
Meanwhile, two teams of GW researchers are focusing their
efforts on the impact of mobile technologies on diabetes care
and management. The teams received grants from the McKesson
Foundation as part of its Mobilizing for Health initiative, a
program geared toward improving the health of underserved
populations through the use of mobile phones.
One study, led by Joshua Cohen, M.D., professor of Medicine in the Division of Endocrinology, and Neal Sikka, M.D.,
assistant professor of Emergency Medicine, will examine
the effectiveness of text messaging in reducing emergency
room (ER) visits by people with diabetes. The team will text
diabetes information to subjects, who will report on their
disease management. Via text, subjects will also be able to
get information about follow-up appointments. The hope is
that by improving patient education, people with diabetes can
improve their self-care and help prevent the type of health
concerns that lead to ER visits.
The other study, led by co-investigators Samir Patel, M.D.,
associate professor of Medicine in the Division of Renal
Diseases and Hypertension, and Katz, will be a randomized,
controlled trial of a cell phone application for patients with
diabetes and hypertension. Patients will be able to monitor
their blood glucose and blood pressure, and share that data
with primary care providers. Researchers aim to create a sustainable care model centered on the cell phone application. n
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NITRIC OXIDE DISCOVERIES UNRAVEL PATHWAYS
LEADING FERID MURAD TO THE NOBEL PRIZE — AND Gw

T

he question had puzzled doctors for

more than 100 years: How did nitroglycerin
— the same explosive compound Alfred
Nobel famously tamed in his invention
of dynamite — work as a therapeutic?
They knew it flushed blood into the heart,
alleviating painful conditions like angina, but
how? That was the million-dollar question.
For Ferid Murad, M.D., Ph.D., now University
Professor and professor of Biochemistry and
Molecular Biology in the GW School of Medicine and
Health Sciences (SMHS), the answer struck like a lightning
bolt. He was a young faculty member at the University of
Virginia (UVA) when he realized nitroglycerin and other blood
vessel–widening drugs (which he dubbed nitrovasodilators)
were being converted to nitric oxide (NO) in the body.
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“That was heresy,” says Murad. After all, NO was best
known as a toxic gas and environmental pollutant — not as
a molecule with beneficial biological functions. But when
Murad and his team linked lab-generated NO with a family
of enzymes called guanylate cyclase (GC), they successfully
mimicked the lock-and-key combination nitroglycerin uses to
make blood vessels relax, expand, and encourage blood flow.
“We did that experiment on Dec. 2, 1976 — I’ll never
forget it,” he says. “It was one of those ‘eureka’ moments.”
And it wouldn’t be the last. Two years later, Murad postulated that nitrovasodilators work not by being converted to
NO in the body, but by prompting smooth muscle cells to
create the gas themselves. NO, he thought, was behaving as a
messenger molecule — one uniquely capable of both carrying
messages between cells (i.e., a first messenger) and entering
the cells to regulate their functions (i.e., a second messenger).
And though it took years to prove it, and even longer for the
scientific community to accept it, Murad was right.

An inteLLeCtuAL Bridge
The memory of a molecule once outcast seems distant to
Murad now — 35 years since the discovery of NO’s first
biological effects and 13 since he and two colleagues won
the Nobel Prize in Physiology or Medicine for it. Today, the
study of NO is one of the most popular in biology, generating
about 130,000 academic papers each year. Murad estimates
the molecule has influenced breakthroughs in cardiovascular
disease, cancer, and arthritis, and — Murad proudly reports
— formed the basis for Viagra. “It’s just remarkable what it
can do,” he says. “If you were asked: Does it do this? Does it
do that? Chances are, the answer is ‘yes.’ ”
The same could be said of Murad, who has served as
chief of Medicine at Palo Alto Veterans Hospital, chair of
Medicine at Stanford University, and most recently director
emeritus of the Institute of Molecular Medicine at the University of Texas Health Science Center at Houston. He’s founded
several biotechnology companies, served as an advisor to
city and government leaders on technology development, and
lectured around the world. In June, he became the namesake
of a hospital in Macedonia — the same hospital where his
Albanian father sold candy as a teenager.
Through it all, Murad’s philosophy has remained the
same. “I like to chase problems,” he says. “You have to do
whatever it takes to answer the most important questions.”
Most recently, “whatever it takes” comes in the form
of GW, where, as University Professor — the institution’s
highest academic title — Murad teaches an undergraduate
course, mentors medical and postdoctoral students, and leads
a lab program in SMHS’s Department of Biochemistry and
Molecular Biology, where he is a full professor. “Something
significant is happening at GW, and it’s fun to be a part of
it,” he says.
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And according to University and SMHS leadership,
Murad’s not just a part of it — he’s driving it. “Dr. Murad’s
presence on our faculty immediately catalyzes and elevates
our strategic efforts in advancing scientific discovery, educating the next generation of physicians and scientists, and
improving the health and lives of the people we treat,” says
Jeff Akman, M.D. ’81, G.M.E. ’85, interim vice provost for
Health Affairs and dean of SMHS. “In many ways, he is an
intellectual bridge between the University and SMHS.”
Rakesh Kumar, Ph.D., professor and Catharine Birch &
William McCormick Endowed Chair of the Department of
Biochemistry and Molecular Biology, and long-term collaborator of Murad’s, agrees. “Dr. Murad is a compassionate
colleague and mentor whose infectious intellectual curiosity
is sparking a fresh spirit of creativity on our campus.”

one pervASive pAthwAY, three importAnt projeCtS
When Murad joined the GW faculty in April, he unpacked
three nagging questions: Can deadly tumors be treated with
minimal side effects? How can stem cells be manipulated to
grow into certain tissue types? Is there a cheap and portable
way to save the millions of lives lost each year to diarrhea?
While ostensibly quite distinct, each project stems from the
cellular signaling pathway that begins with NO and ends
with cyclic guanosine monophosphate (cGMP), a second messenger that is released inside a cell after GC is activated by
NO (i.e., the lock and key).
“NO and cGMP reprogram genes that influence the differentiation and proliferation of cells,” explains Murad of
project number one. “Because some of these effects are related
to cancer proliferation, interrupting that process can be a
novel way to treat cancers.” It’s a thought that’s been simmering in Murad’s mind since the 1970s, when his work with
liver and renal tumor models first indicated a relationship
between cGMP and tumor proliferation. After several years
exploring this relationship — and even demonstrating that
cGMP excretion in the urine of rats correlated with the size of
their tumors — Murad and his colleagues tabled the project
because their ambitions exceeded the day’s technologies.
In recent years, Murad has returned to the pursuit, this
time focusing on glioblastoma, a “very aggressive, nasty”
type of brain cancer that Murad estimates kills up to 80 percent of its victims in less than three years. His goal, in broad
terms, is to enhance the expression of a certain subtype, or
isoform, of the receptor GC and its product cGMP so that
the message “grow” cannot be received by the tumor cells.
So far, Murad and his team of investigators have successfully
quadrupled the life span of mice injected with manipulated
tumor cells. “Can we do that with humans? I don’t know, but
I hope so,” he says.
Murad’s second project, regenerative therapy, goes hand in
hand with his first. Like cancer cells, embryonic stem cells are

proliferating and differentiating systems whose growth and
change is dependent upon the messages they receive. If Murad
can understand whether and how much NO and cGMP
dictate the messages that tell embryonic stem cells what kind
of tissue to become, he might also be able to swoop in and tell
them to be something else.
So far, Murad and his colleagues have coaxed cell lines
toward futures as hearts and brains. But, of course, cGMP
and NO are only part of the story, Murad cautions. “It’s
going to be a complicated cocktail of goodies you put in your
cultures to become this or that, and I think part of the story
will be cGMP or NO.”
In 20 or 30 years, he predicts, the “organ transplant
program won’t be necessary anymore. Wouldn’t that be
wonderful?”
The third research goal also dates back to the 1970s,
when Murad helped a colleague at UVA reveal that a bacterial toxin in Bangladesh was causing diarrhea by increasing
cGMP production, similar to how cholera causes diarrhea by
increasing the production of another second messenger, cyclic
adenosine monophosphate (cAMP). The pair demonstrated
that the only isoform of GC found in the intestinal mucosa,
particulate GC, is the receptor for the bacteria’s heat-stable
strain. When that strain interacts with the particulate GC,
the lock-and-key match unleashes cGMP and prompts diarrhea — an illness responsible for the death of about 2 million
children worldwide each year.
Ever since, Murad has been on the hunt for the perfect
compound that plugs the lock between the toxin and the particulate GC receptor. He and colleagues have already found
one particularly promising molecule that works with both the
bacterial toxin and the cholera toxin. And while there is still
“homework to do” on the compound, including clinical trials
for toxicity, Murad is optimistic that a marketable therapeutic
will be developed in his lifetime. “If we can make an impact
on cancer, if we can make an impact on stem cells, and if we
can figure out a way to treat infectious diarrhea in third-world
countries, I will turn up my toes and feel blessed,” he says.

A prodigY of nAture And nurture
Even as a “youngster,” Murad knew he would go to medical
school. He had always been smart — remaining at the top of
his class from grade school through high school, despite rarely
doing homework — but his desire for higher education was as
attributable to nurture as it was to nature, he says. Raised in a
small town in Indiana, Murad learned the value of hard work
and education from his restaurant-owner parents, neither of
whom had completed elementary school. “I knew that when
I grew up, I wanted to accomplish more than my parents,” he
recalls. The other important component of success, says Murad, “is identifying that teacher or professor who will get you
excited about something, guide you, and keep you going.”

When Murad joined the GW faculty
in April, he unpacked three nagging
questions: Can deadly tumors be treated
with minimal side effects? How can
stem cells be manipulated to grow into
certain tissue types? Is there a cheap
and portable way to save the millions
of lives lost each year to diarrhea?
For him, there were many — high school teachers who
were regulars at his parents’ restaurant, professors during
his undergraduate years at DePauw University, doctors in
residency at Massachusetts General Hospital, and scientists
at his fellowship at the National Institutes of Health. But it
was while achieving one of the nation’s first dual M.D./Ph.D.
degrees at Case Western Reserve University that Murad met
his two most influential mentors: Earl Sutherland Jr., M.D.,
chair of the Department of Pharmacology, and Theodore
Rall, M.D., a young faculty member in the same lab.
Murad joined their lab shortly after it had discovered
cAMP as the first intercellular second messenger — a finding
for which Sutherland later won a Nobel Prize. “What a wonderful and exciting time … watching a new area of biology
develop and actively participating in the work,” writes Murad
on the Nobel Foundation website. He has studied cellular
signaling ever since.
Murad has also embraced the opposite side of the mentorship dyad, training about 150 medical students and fellows
in his lab over the course of his career. Many have become
department chairs, several are company presidents, and one is
the president of a Japanese university, but none have won the
Nobel Prize … yet. “One of my students has to win the prize
because I don’t want this lineage in cellular communication
disrupted in any way,” says Murad, half-joking and alluding
to the three-generation trend that began with Sutherland’s
mentor, Carl Corey, who won the prize in 1947 for describing
how the body uses glycogen for energy. “One of my goals is
to identify that next generation here at GW.” But even more
than the Nobel trait, Murad hopes he can pass down his
passion for research and penchant for problem solving. After
all, if conducting one revolutionary experiment was his only
goal, Murad could have stopped that winter night in 1976.
But “quitting while you’re ahead” is an idea that’s never made
much sense to Murad. “I hope I never retire,” he says. “I really
love what I do — solving problems. How long I can go, I don’t
know. But I am willing to find out.” n
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“Order and simplification are the first steps
toward the mastery of a subject.”
— Thomas Mann

Deconstructing a
Complex Disorder
A GW researcher applies order and simplification as
a new step toward understanding autism

On a Wednesday last April, Valerie Hu, Ph.D., professor
of Biochemistry and Molecular Biology at GW’s School of
Medicine and Health Sciences (SMHS), eagerly anticipated
the release of an autism spectrum disorder (ASD) study that
she authored and that appeared in the online science journal
PLoS One. The study added to an already large body of
literature linking specific genes to autism, but Hu emphasized
that her genome-wide analysis provided “a new twist.”

Hu’s approach addressed the immense variability of
autism, a disorder that affects one out of 110 American
children, according to the Centers for Disease Control and
Prevention. Autism’s severity and symptoms vary drastically:
They include language deficiency, repetitive behaviors,
and restricted social interest; some individuals also exhibit
epilepsy, sleep disturbance, weak muscle tone, and immune
system dysfunction. “When I talk to parents about studying
autism,” Hu says, “I tell them it’s like digging your hand into
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a bowl of mixed fruit and picking out one specific thing.”
Experts agree that autism is a multi-gene disorder, and
each gene inflicts a small effect that is compounded by
environmental factors. The unique jumble of symptoms
emerges in almost a case-by-case basis. “This heterogeneity in
symptoms, severity, etc., is the major problem,” Hu explains.
“Most scientists and geneticists recognize this, but little
has been done to tease the heterogeneity apart. The result is
increased ‘noise’ in the biological or genetic data.”

the BreAkdown
Hu’s recent study seeks to squelch that noise and gain a
clearer signal by systematically grouping individuals with
autism into subgroups according to similarity of severity
scores from the Autism Diagnostic Interview–Revised
(ADI-R), a behavioral diagnostic assessment. These scores,
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along with the corresponding individual’s genetic data, were
obtained from a large study led by faculty at the Children’s
Hospital of Philadelphia.
Hu clustered nearly 3,000 individuals into four
distinguishable ASD groups that ranged in severity from mild
to severely language impaired, with the hope of determining
whether the behavioral subtypes could be associated with
different genetic variations.
This study identified 18 novel genetic variants or single
nucleotide polymorphisms (SNPs) that were associated
with one or more subgroups of autism. Interestingly,
the SNPs were in regions of DNA that didn’t code for
proteins, suggesting that they may instead regulate gene
expression. The value of dividing individuals into subgroups
for the genetic analyses was underscored by the fact that
no significant SNPs were identified when the cases were
combined into a single group (Hu’s “bowl of mixed fruit”).
“To associate genotype with behavioral phenotype is what
you want for diagnostics,” Hu says. “You want to pick out
not just risk for autism, but also risk for a type of autism.”
Anthony-Samuel LaMantia, Ph.D., professor of
Pharmacology and Physiology and director of GW ’s new
Institute for Neuroscience, stresses the importance of taking
into account autism’s variability when connecting observable
deficits to their underlying genome. “It’s not as simple as
making a clinical diagnosis of autism and then finding
a gene,” he says. “There’s a necessity in identifying each
behavioral realm and associating it with a number of genomic
changes. These sorts of groupings will help with that.”

pAtternS emerge
The success of this genome-wide genetic analysis in
identifying subtype-dependent SNPs supports this subtyping
strategy, which Hu and her colleagues had previously applied
to genome-wide gene expression analyses. In a 2009 study
that analyzed more than 40,000 RNA transcripts per sample,
both overlapping and unique genes were revealed among
three of the subtypes examined.
Among the genes shared between the severe and mild
subtypes were those linked to cell death, inflammation,
embryonic development, memory, learning, and muscle tone.
Unique to the more severe ASD group were genes associated
with responses to painful and normal stimuli, muscle rigidity,
epilepsy, and circadian rhythm.
Altogether, Hu views her findings as necessary steps
toward targeted therapies in autism. “In order to develop
a personalized medicine approach to treating a complex
disorder,” she says, “you need to define what the defect is.”

it’S perSonAL
With good reason, Hu decided in 2004 to pivot her research
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acumen toward autism. “I have a son who’s affected.
That’s my driving motivation,” she explains. As a parent
and a scientist, she is all too aware of how the diagnosis of
autism relies solely on behavioral assessments, since reliable
biomarkers have yet to become a reality. “Even though
autism is said to be highly heritable, there’s still no genetic
or molecular marker,” she says. “So one of the goals of our
study was biomarker identification.”
With regard to the diagnostic landscape of autism,
Rakesh Kumar, Ph.D., professor and the Catharine Birch &
William McCormick Endowed Chair of the Department of
Biochemistry and Molecular Biology at SMHS , couldn’t agree
more about the need for a quantitative tool. “There is no
yardstick to measure autism against,” he says. “There is a lot
of subjectivity that comes with complex disorders, and they
cannot be assigned to one single gene product. This is where
Dr. Hu’s work will be able to fill in the niche.”
Absent a biological understanding of autism, treatment
options are limited and vulnerable to conjecture. “Right now
they’re just throwing all these different psychotropic drugs
at autistic kids,” Hu observes. “My son has been prescribed
more than 20 different drugs. None of the drugs have
worked, and many have had intolerable side effects, so now
he’s not on anything.”
Ideally, making a diagnosis based on peripheral
biomarkers stems from an understanding of how the detected
changes relate to the nervous system, LaMantia points out.
“The diagnostic strategy requires asking whether peripheral
change in a non-neuronal cell type represents something
significant in the nervous system,” he adds.

A frAmework for the Big piCture
Making sense of autism means unraveling its many causes and
seeing how they relate. Hu likes to construe it as a multilevel
pyramid with the base representing the observable symptoms,
or phenotype. The next level is the gene expression profile,
above which is the genetic hardware that you’re born with
as well as the ways in which that hardware is interpreted, or
epigenetics. At the top are the environmental and biological
triggers, such as hormones and toxins. “Even though autism is
highly genetic,” Hu notes, “the question is what environmental
factors impact the genes. That’s the big picture.”
Because genetically identical twins who differ in their
diagnosis for autism show different gene expression profiles,
Hu thought it was a good idea to look at DNA methylation,
an epigenetic process whereby methyl groups attach to DNA
to dampen gene expression.
In a 2010 study, Hu and Anh Thu Nguyen, then a
graduate student working in Hu’s lab, identified the retinoic
acid-related orphan receptor alpha gene, or RORA, as
a gene that’s altered by methylation in samples from
autistic individuals. RORA mutation has been linked to

Valerie Hu, Ph.D.

“Even though autism is said to be highly heritable, there’s still no genetic or
molecular marker, so one of the goals of our study was biomarker identification.”
an abnormal cerebellum (the region of the brain that’s
responsible for coordination and muscle tone) and
deficiency in a type of neuronal cell (Purkinje), which has
been the earliest and most consistent brain abnormality
observed in autism.
This February, Hu and her collaborators — Tewarit
Sarachana, a GW Institute for Biomedical Sciences Ph.D.
candidate, Minyi Xu, a master’s degree student in Biochemistry who now serves as a research assistant under Hu; and
Ray-Chang Wu, Ph.D., assistant professor of Biochemistry
and Molecular Biology — reported that RORA is regulated
in opposite directions by male and female sex hormones
(male hormones repress it), and also that RORA regulates aromatase, an enzyme that converts testosterone to
estrogen. The study further showed that both RORA and
aromatase levels are reduced in the brain tissues of autistic
individuals, thus linking observations initially made with
non-neuronal tissues to changes in the brain. These findings
are significant because they provide an explanation for the
higher amount of testosterone often seen in children with
autism, which some researchers blame for the 4:1 sex difference between boys and girls with the disorder.
“I think females are more protected because estrogen
can not only elevate RORA expression, but also compensate for a deficiency in RORA by activating the estrogen
receptor which controls some of the same genes that are
regulated by RORA,” Hu says. “That’s what I think is
the beauty of the work with sex hormones. It really helps

explain the higher levels of testosterone, as well as the sex
bias in autism.”

eYeS on the prize, feet on the ground
Hu explains her work like a driven detective searching for
clues. Kumar describes her as a principal investigator who
single-handedly put GW on the map for autism research. “Her
work,” he says, “will collectively help to further refine the
autistic diagnostic kit based on objective, quantitative tests.”
Hu hopes her work will one day spur better diagnosis
and treatment of autism. “Sometimes when you think too far
ahead, it’s so complex,” she reflects. “You wonder whether
you’ll get to a point where you can really help.”
LaMantia agrees that solving the riddle of autism will be a
piecemeal, formidable challenge. “Autism research is moving
forward right now,” LaMantia observes, “but it is going to be
complicated, and it will move forward ever so slowly.”
It’s understandable that parents of autistic children would
find such an outlook sobering. After Hu spoke about autism
at a recent conference in Utah, a parent asked if giving
estrogen to her affected son would alleviate symptoms. As a
parent and a scientific expert, Hu could relate to the eagerness. But she framed her answer pragmatically: “You have to
let research sort that out.”
Taped to Hu’s computer monitor is a fortune cookie message: “Your present plans are going to succeed.” It’s a sage
reminder for any investigator who has a hunch he or she is
on the right track. n
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The concept of “flow” is a defining characteristic for Ramesh Mazhari. As an
interventional cardiologist, she is dedicated to restoring and improving patient
blood flow to the heart. As a researcher, she has transitioned almost effortlessly
from one new idea to the next. And, with guidance from mentors along the
way, Mazhari hopes to make it possible for basic science discoveries to move
swiftly from concept to patient care. h In the clinic that treats vessel blockages, Mazhari, M.D., G.M.E. ’02, G.M.E. ’05, assistant professor of Medicine
in the Division of Cardiology at GW’s School of Medicine and Health Sciences
(SMHS), has earned a reputation as an expert in the use of transradial catheterization on patients who experience a blockage of blood flow to their hearts. In
the laboratory, pursuing stem cell research to restore heart muscle function, she
is exploring the molecular level of information flow. She is trying to determine
the pathways that prompt the body to cue — or crush — the cell growth needed
to repair a damaged heart. She hopes one day to harness that signaling system
to devise regenerative cardiac treatments. And as a master’s degree student in
SMHS’s first class of translational medicine specialists, Mazhari is moving to
the next big paradigm in medicine.
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Cardiac Interventionalist Ramesh Mazhari,
M.D., G.M.E. ’02, G.M.E. ’05, prepares to
insert a catheter into the radial artery of a
patient.
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inSight And ACtion
Mazhari, who completed her residency in internal medicine
at GW in 2002 as well as a fellowship in cardiac intervention
at GW in 2005, returned to SMHS three years later as a
member of the Cardiac Catheterization Laboratory at GW
Hospital. With encouragement from her mentor, and now
colleague, Jonathan Reiner, M.D., professor of Medicine
and director of GW’s catheterization lab, Mazhari pursued
training in transradial access. The specialized cardiac
catheterization procedure offers safer access to the heart
through the radial artery in the patient’s wrist rather than
taking the traditional approach through the femoral artery.
The procedure was developed about 20 years ago in
Europe. Although only about 5 percent of cases in the United
States use transradial access, it is now the preferred method
in more than 50 percent of cases in Europe, Canada, and
Japan. The U.S. standard relies on the larger, straighter
femoral artery in the groin as a route to the heart. Both
approaches enable physicians to diagnose coronary blockages,
and, where possible, restore blood flow by threading a stent
through the catheter to prop open the vessel. The femoral
procedure, however, presents bleeding risks and significantly
greater discomfort for the patient due to the artery’s location
deep within the thigh muscle. Transradial access is ostensibly
more difficult because the radial artery is smaller than the
femoral artery, and the route to the heart is less direct (the
physician has to guide the catheter up through the patient’s
arm around the shoulder to reach the heart). Nonetheless, the
procedure is safer because it reduces the risk of bleeding, and
it provides a faster recovery time; patients sometimes go home
on the same day as the procedure.
As is typical of Mazhari’s style, action followed the
insights she gained from her catheterization training. “After
three or four cases, I was convinced that transradial access

was the better procedure for a cardiac intervention because
it’s better for the patient,” she says.
Mazhari suggested to Reiner that GW expand its use
of transradial access, and after some careful evaluation he
adopted his protégé’s enthusiasm for the technique. The
results were so positive that radial access soon became the
lab’s preferred approach.
“It’s a much more patient-centered approach,” says
Reiner. “While the procedure often takes several months
for physicians to really learn, once they have the expertise,
they can perform it just as quickly, more safely, and less
expensively compared with the more common procedure of
going through the femoral artery.”
Most catheterization labs in the United States opt for the
femoral procedure as a first option and switch to the radial
artery only if there is potential for complications with the
traditional approach, according to Reiner. GW turned that
scenario on its head. “Today at GW Hospital, we perform
almost 90 percent of catheterizations through the wrist,” he
says. “The procedural outcomes are equivalent, and patients
prefer it.”
Reiner beams with added satisfaction that the switch to
transradial access was born of homegrown talent. “Ramesh is
someone I trained,” recalls Reiner, “but she has changed my
practice and influenced a generation of our fellows at GW.”
As a result of the transition, GW has become a wellspring
for training in the transradial technique. “Our fellows come
out of their years with us having performed hundreds of
cases, and they really become experts at it,” says Reiner.
Through its fellowship programs, GW provides specialized
training in transradial access for two interventionalists and
eight general cardiology fellows annually. In addition, three
or four established physicians travel to GW each month to
learn the technique.

“Ramesh is someone
I trained, but she has
changed my practice and
influenced a generation
of our fellows at GW.”
— Jonathan Reiner, M.D.,
director of GW’s
catheterization lab
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Connect. Flow. Transform. It’s an algorithm for speeding
the current of innovation to patients. Mazhari attributes her
inspiration in exploring new channels of care to the many
influential mentors who have guided her along her relatively
young career as a physician.
“A great mentor is not just a doctor who teaches you
how to perform a procedure the way he or she does, or how
to understand a condition based only on their own experience,” Mazhari explains. “A great mentor teaches you to be
imaginative, to think differently, and to continue to learn as
much as you can.”

of pig LABS And prACtiCe ChAnge
Mazhari’s drive for “different and better” was instilled
early in her medical career during a fellowship at Boston’s
Brigham and Women’s Hospital. Developing a research
project taught her the fine-grained details of how to build
an operational foundation for research, including managing
stakeholder input, policy implications, grant requirements,
and reporting mandates. Right away Mazhari knew she
wanted a career in both research and patient care. At the
time, however, translational medicine — quickly moving
advances in research from the bench to better clinical care
at the bedside — was only beginning to take shape at a few
academic medical centers.
Again, mentoring made the difference for Mazhari.
Working on another fellowship under Joshua Hare, M.D.,
who was a pioneer in the use of stem cells for repairing damaged heart muscle and was then at Johns Hopkins University,
Mazhari realized that her dual expertise in research and
patient care was clinically relevant. During the year-long
fellowship, she found herself in the lab as a basic science
researcher investigating stem cells and their impact on the
heart physiology of pigs. Pigs are routinely used in cardiac
research because their heart anatomy is similar in size,
structure, and function to that of humans. Mazhari’s task
during the project served as a counterpoint to her current role
as an interventional cardiologist. “Instead of clearing vessels
to restore blood flow, I was trying to close vessels to induce a
heart attack in the pigs,” she explains. “Then we would inject
cardiac stem cells to see if there was any therapeutic effect on
the heart. In doing a little bit of everything — basic science
research and clinical care — I really found my calling.”

CreAtive CoLLABorAtionS
Mazhari kept seeking a link between science and patient
care. Upon her return to GW in 2008, she found a fertile
environment in which to integrate her understanding of clinical care and her interest in hard science. The combination
of freedom and direction offered by mentors such as Reiner,
Timothy McCaffrey, Ph.D., professor of Biochemistry and

Molecular Biology, and Eric Hoffman, Ph.D., professor of
Pediatrics at GW’s SMHS and Children’s National Medical
Center, enabled Mazhari to reach beyond convention.
This spring she joined one of the nation’s few translational
medicine degree programs — and the only one in the Washington, D.C., area. Mazhari is among GW’s inaugural class
of 15 M.D.s and Ph.D.s training to bridge gaps in care and
build new platforms for improved health by quickly translating advances in basic science into new clinical treatments
for patients. The degree program is part of a partnership
between GW and Children’s National Medical Center thanks
to a National Institutes of Health grant — the prestigious
Clinical and Translational Science Award.
Joseph Bocchino, Ed.D., M.B.A., assistant professor and
chair of SMHS’s Department of Clinical Research and Leadership, directs GW’s new degree program. He believes translational medicine exerts new demands on leaders to evolve
beyond the rapidly declining model of care marked by the
heroic surgeon, the lone genius in the lab, the solo clinician.
“This emerging domain is all about a social-networking
approach to problem solving,” Bocchino explains. “It’s done
largely through multidisciplinary teams, not isolated or loosely
affiliated individuals. So the process requires a new leadership
style. Defining and developing this new leadership style is one
of the essential educational pieces of our program.”
He adds that traditional research programs train people in
a deep, but narrow, scope of interest. “In this new program,
the strategy is to help people develop a broader base of experience across the continuum, from basic science, to clinical
research, to matters of health policy.”
Mazhari explains, “I was attracted to the opportunity to
enter GW’s translational medicine degree because I had firsthand experience both in basic heart research and in applying
new knowledge to patient care.”

mAking the ConneCtion to Better CAre
Translational medicine is changing how scientific research
is conducted and health care is delivered in the U.S. because
it’s helping to overcome medicine’s past problems: A system
fragmented between basic laboratory research, clinical care
of patients, and policy support for best-practice methods and
therapies.
“In health care right now, there is a huge gap between
what we know and what we deliver,” says Mazhari. “My
job as a clinician going through this program is to connect
those two worlds through translational research. My goal
is to take the rapidly growing basic science research, and
use those techniques to try to answer very relevant clinical
questions. It’s exciting to have this opportunity because in
medicine, there’s so much more we can do for patients when
we can make this connection.”
Connect. Flow. Transform. n
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Total Number of Refugees by Country Living in the United States 2010
Top 10 countries

Russian Federation
7,403

Albania
7,842
Armenia
6,637

Haiti
18,487
Columbia
25,607

Ethiopia
11,421

Venzuela
5,675
Cameroon
7,300

China
54,599
India
7,842

Source: UNHCR Statistical Online Population Database

Prescriptions for Sanctuary
for refugeeS, MedicAl eVAluAtionS by gw cliniciAnS cAn MeAn tHe difference between life And deAtH

A

lot of things seem to walk away from Katalin
Roth’s office, which, she admits, is “due for a
clean.” But a simple greeting card isn’t one of
them. She locates it swiftly, plucks it off the
bulletin board, and reads it aloud.
“Thank you very much for everything you have done,” it
says. “You saved my life. As a Burmese, I worship you every
day for saving my life.”
“Isn’t that amazing?” Roth marvels. “It’s the most
amazing card I’ve ever received.”
Roth, M.D., J.D., is the division director of Geriatrics
and Palliative Medicine at the GW Medical Faculty Associates and an associate professor in the Department of Internal
Medicine at the GW School of Medicine and Health Sciences
(SMHS). As a doctor, she is in the business of saving lives. As
a volunteer medical evaluator of asylum seekers, she helps refugees like the card’s author — a journalist who fled a country
where her profession is a crime — create new lives. Her two
roles are not that different. After all, as Roth wrote in a paper
published in the Journal of Pain and Symptom Management,
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By Anna Miller
“helping a refugee achieve legal status in this free country is
really to save a life.”

the meAning of ASYLum
The word “asylum” literally means “sanctuary.” Legally, it
is the right to remain in the United States despite an expired
visa or illegal entry, and the ability to eventually apply for
U.S. citizenship. Symbolically, it means freedom. No matter
how it’s spelled, achieving asylum isn’t easy.
To earn it, asylum seekers (also called asylees) must prove
refugee status — they must show that past persecution or a
well-founded fear of future persecution prevents them from
returning to their home countries, and that such persecution
is based on race, religion, nationality, political opinion, or
membership in a particular social group. Because asylees often
lack documentation, testimony from a medical evaluator like
Roth can be the difference between life and death.
Roth conducts her evaluations at Washington, D.C.’s
Bread for the City, a nonprofit clinic that provides adminis-

Roth’s documentation, Annie was eventually granted asylum
and is now a home health aide, a wife, and a mother.
“While working with Annie, I discovered a new dimension of myself as a physician,” says Roth. “I had been a
physician-advocate before … but in this work, I could help
individuals address international injustice.”
Roth also shares a personal connection with the refugees.
Despite having survived persecution as Jews during World
War II, Roth’s family fled Hungary when she was three
months old because her father, a small business owner, was a
capitalist in a communist regime.
“I grew up hearing the stories of our escape, about the
bullets whizzing by as the truck driver drove through a
checkpoint, and the fellow passenger who was killed in the
escape,” Roth recalls. “So I know firsthand … that immigration is a choice one makes when one has no other choices.”
Katalin Roth, M.D., J.D.

PhotograPhy by MIchael leong

trative support for volunteer physicians, among other services
to the community. She takes a medical history, conducts a
physical examination, and asks a lot of questions — about
the abuse, the escape, detention conditions, and methods of
torture. She asks about life “before,” and life “after.”
The most important part of Roth’s job is the listening. It’s
also the hardest.
Stories of rape, beatings, starvation, and burning; tales of
amputated fingers, crushed legs, stretched arms, and sliced
skin fill her asylum interviews. She has documented genital
mutilation, chronic fungal skin infections, and severe arthritis.
Though not all scars are visible, the stories are chilling.
They are acts of torture not accidents. They are deliberate and
cruel, and, perhaps worst of all, they represent only a fraction
of the tortures inflicted daily in more than half the world’s
countries. Those who make it to Roth are the lucky ones.
“You learn a lot about how terrible people can be to one
another,” says Roth, who has examined people from the
Ukraine, Georgia, Pakistan, Ethiopia, Albania, Sudan,
Guatemala, and more. While in the clinic, she remains sympathetic but detached. “Later, in the privacy of my home,”
she confesses, “I have shed tears.”
But her tears are fleeting. The people are inspiring, interesting, and often very brave, she says. “They have the courage
of their political convictions and stand up to governments.”

A phYSiCiAn AdvoCAte
Roth’s first patient came to her by way of her colleague Julia
Frank, M.D., professor of Psychiatry and Behavioral Science in SMHS, who had been performing psychiatric evaluations of asylum seekers for about five years. Annie was a
“thin, frightened young woman” from Cameroon who had
been arrested and abused in prison presumably because her
boyfriend was a political activist. With the help of Frank and

we don’t ASk
Roth’s experiences with refugees are valuable in the clinic,
where she argues that doctors know too little about their
patients. “We don’t ask the veterans what happened in the
war, whether it’s World War II, Korea, or Vietnam. We don’t
ask foreign-born patients what kind of turmoil they went
through. And so we miss out on knowing our patients.”
Physicians also risk missed diagnoses, she says. Depression, stomachaches, headaches, and eczema can all be related
to past traumatic experiences.
What’s more, “medical care itself can be traumatic to
people who have been traumatized,” according to Frank.
Clinic rooms can mirror prison cells, clinicians’ questions can
echo interrogations, and medical tools can resemble instruments of torture.
It’s an idea illustrated by one of Roth’s patients, a 70-yearold Vietnamese-American man named Nguyen who was
crying as he recovered from lung surgery. He told Roth he was
not in pain — as long as he remained still. And yet, lying still
was almost worse: The position reminded him of the torture
he had endured as an anticommunist in South Vietnam, where
he was confined to a cage, unable to stand for six months.
“Nguyen helped me understand how helplessness can be
re-created in the medical setting and how easily long-buried
memories of torture can be reawakened in illness,” says Roth.
Back in her office, before reading the greeting card, Roth
received a phone call about a patient in her geriatric clinic who
died. She empathized with the caller, admiring the deceased
and wishing the family her best. With the click of the phone
and a mark on her chart, another patient was lost forever.
As a physician, Roth is also in the business of watching
lives pass.
“It’s sort of an antidote, I guess,” she says as she pins the
card back on the bulletin board. In Roth’s world, for each life
lost, another is saved. n
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Orthopedic Surgeon Ken Akizuki, M.D. ’93, keeps the San Francisco Giants standing tall.

There When Giants Fall
orthopedic Surgeon ken Akizuki, m.d. ’93, works to keep major Leaguers
on their feet and rounding the Bases
By Gary Libman

As he anticipated the final out in the World Series last November, Ken Akizuki, M.D. ’93, ran from the San Francisco
Giants’ clubhouse to the end of a tunnel behind the team’s
dugout. When the Giants won, the team’s orthopedic surgeon followed the hugging, screaming, jumping players onto
the field to celebrate.
The next day, Akizuki rode in the team’s victory parade
through downtown San Francisco. A sea of confetti coated
a roaring sidewalk crowd estimated at more than 1 million.
Later, the Giants awarded Akizuki the same World Series
ring the players and coaches received.
“I wear the ring every day,” Akizuki says. “And every day
my patients want to wear it and take a picture with it. I think
they are more interested in my ring than they are in me.”
Celebrating the World Series championship with the team and
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owning a World Series ring are just two among many fantasy
“perks” Akizuki receives as the Giants’ orthopedic surgeon.
He doesn’t have to search to uncover the path that led
him to this moment. For Akizuki, it began during his final
year as a student at GW’s School of Medicine and Health
Sciences (SMHS), as he prepared to pick a residency.
“It was tough to choose a specialty, because as a student
you wanted to emulate the professors you liked and looked
up to,” recalls Akizuki. “But the seed to go into orthopedics
was probably implanted in my fourth year of medical school.
My GW professors helped me get a great residency in general
surgery at Los Angeles County Harbor–UCLA Medical
Center, and when I went into the residency I felt that my
education was as good as what was provided by any medical
school in the country.”

He adds, “I can’t tell you how many other professors
and people touched my life. My classmates and faculty were
tremendous. The impact of the mentors and other people I
met was invaluable. I was helped a great deal by a couple
of orthopedic residents: Ken Yamaguchi, now the Sam and
Marilyn Fox Distinguished Professor of Orthopedic Surgery
at Washington University School of Medicine in St. Louis,
and Ammar Bafi, who was the chief resident in General
Surgery and is now a cardiovascular surgeon at Washington
Hospital Center.”
In his role with the Giants, Akizuki works at nearly all of
the team’s 81 home games and spends another three weeks
with the team during spring training. That’s in addition to
his full-time practice.
Akizuki works the games not just because he’s been a
Giants fan since childhood, and not just because in the clubhouse he regularly encounters Major League Baseball royalty,
such as former Giant Willie Mays or such current players as
two-time Cy Young Award winner Tim Lincecum. He’s at
the clubhouse because he feels responsible to the players.
“Baseball’s a funny game,” says Akizuki, 45. “The
majority of injuries are a result of repetitive stress, and the
more you are around, the more you get to see the evolution
of injury and you get to know the athlete and they get to
see you. The more you’re around and the better the players
know you, the more they trust you.”
Akizuki starts each season with the Giants in late February
at spring training in Scottsdale, Ariz. He and other team doctors provide physicals for the Giants’ 180 to 200 major and
minor league players and treat frequent pre-season injuries.
When the season begins in early April, he frequently
works 15-hour days. On nights when the Giants play at
home, he sees private patients from 7:30 a.m. to 5:30 p.m.
and plants himself in the Giants’ locker room from 6 p.m. to
11 p.m.
When he arrives at the locker room, “There’s usually a
list of players I need to see, and I prioritize those,” he says.
“Some may be playing that night. I’ll usually meet with
the player and training staff and make decisions. Often the
player will have taken batting and infield practice. Afterward, we’ll assess how they’re doing. It’s a long season and a
grind. The players are always banged up a little, some more
than others, and you’ve got to make decisions on a day-today basis.
“I try to multitask, doing paperwork from my practice
during the game,” Akizuki continues. “I’m pretty intent on

watching the game on a monitor in the clubhouse. A lot of
players who are preparing to play in the later innings leave
the dugout and come into the clubhouse. They have their
rituals to get ready; like relief pitchers who come in and get
stretched out. Guys who’ve been injured for a long time come
in to rehab, and I talk to them. We watch the game together.”
He adds, “The hardest thing about the job is that the
training staff and I have to make a lot of tough decisions in
terms of injuries. People always want to know how quickly
we can get these guys back on the field; our job is to do so
safely and do it right.”
Among those Akizuki has successfully treated were two
players struck in the head at separate times by a batted ball,
one on the mound and the other in the dugout. But common
complaints, especially among pitchers, include labral tears,
impingements, tendinitis in the shoulder, and ulna collateral
ligament problems in the elbow.
As a pitcher–infielder at Branham High School in San
Jose, Akizuki personally avoided these injuries. Unfortunately, he adds, the injuries, once confined to professionals,
are becoming more common among amateur athletes.
“The most concerning thing I see,” he says, “especially
in youth baseball, is that kids are getting the same injuries
in the shoulders and elbows at a much younger age. At 37,
a guy has had a major league career. But at age 12, the concern is that if you’re getting an operation on your shoulder
or elbow, how long will the player last? Will they last
through high school or college or even professional baseball
if that’s their goal?”
Akizuki ’s grateful that the medical school stressed the
importance of treating not just the injury but the whole
person. “You are taught the physiology and the anatomy,” he
says, “but you’re also taught to always remember that you’re
dealing with a human being.”
After applying what he learned during his residency at Los
Angeles County Harbor–UCLA Medical Center, Akizuki was
immediately invited in 2000 to join the Giants medical team.
He became the team’s orthopedic surgeon in 2004.
As he’s working in the locker room, he frequently
sees Mays and other noted former Giants, such as Willie
McCovey and Orlando Cepeda, but it’s the current staff who
receive the bulk of his attentions.
“I try not to get involved in players’ lives,” Akizuki says. “I
need to be their doctor and maintain objectivity and distance.
Inside me, it’s like a dream. This is the team you rooted for as
a kid. I want to be a fan and root for them. But you can’t act
like a fan. You’ve got to be professional.” n

M E D I C I N E + H E A LT H

27

rEsidENT ProFiLE
in 2006, according to CDC reports,
they account for almost 20 percent of
multiple births nationwide. For many
women, multiple-birth pregnancies
are not just undesirable — they are
dangerous, posing a higher risk of
complications, including preterm births
and low birth weight.
Ambroggio’s study, called “Multinucleation of a Sibling Blastomere
on Day 2 Suggests Unsuitability
for Embryo Transfer in In Vitro
Fertilization — Preimplantation
Genetic Screening Cycles,” explores
new methods of predicting which
embryos are healthiest and best suited
for implantation, a technique that could
lead to both an increased likelihood
of a successful pregnancy following
IVF and a reduction in the number of
Medical Resident Jennifer Ambroggio, M.D. multiple-birth pregnancies. The study
was published in the American Society
for Reproductive Medicine journal Fertility and Sterility (v.
94, n. 4, p. S127).
Ambroggio and researchers at the GW IVF Center
analyzed cells from 1,189 three-day-old embryos to test for
Medical Resident JennifeR aMbRoggio looks foR
aneuploidy — genetic damage resulting in any number of
new Methods foR identifying the best eMbRyos
chromosomes other than the normal 23. Their data showed
to ensuRe successful iMplantation
that embryos containing multinucleated blastomeres, even
when found to be normal following preimplantation genetic
diagnosis, did not result in any successful pregnancies.
Blastomeres are the cells that make up an embryo
A decade ago, Jennifer Ambroggio, M.D., was a seasoned
during
its first few days of development. During normal
embryologist living in California with her husband and
meiosis,
each cell nucleus must replicate itself. When the
young child. But something wasn’t quite right. “I felt isolated
cell divides, sometimes the nucleus will double itself but
in the lab,” she remembers. “It was my relationship with
the cytoplasm won’t divide, resulting in a multi-nucleated
the patients who benefited from my work that was the most
blastomere. “Not every embryo, even one created in vivo, is
fulfilling.” So Ambroggio and her family packed their bags
genetically normal,” says Ambroggio. Those with inherent
and moved east, so she could attend medical school.
genetic abnormalities are more prone to multinucleation, she
Now, Ambroggio, a resident at GW’s School of Medicine
explains.
and Health Sciences (SMHS), is glad she made the move —
Ambroggio concluded that given the choice, physicians
and GW is glad too, presenting her with the 2011 Clinical
should
pick an embryo without multi-nucleated blastomeres.
Research Award during this year’s Research Day for a study
“Or, if you have a lot of embryos to choose from and you are
that could influence future assisted reproductive technology
undergoing preimplantation genetic testing,” she adds, “you
(ART) procedures.
can forgo biopsying those embryos with multi-nucleated
Patients undergoing ART procedures, such as in vitro
blastomeres, because you can be pretty certain that they’re
fertilization (IVF) or fertility drug treatment, are more likely
not going to lead to a pregnancy. This would save money for
to have multiple-birth pregnancies than women who conceive
patients, and help them achieve better outcomes.”
naturally. Although just 1 percent of the infants born in the
United States were conceived through some form of ART
28 GWUMC.EDU • F A L L 2 0 1 1

—Thomas Kohout
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FACuLTy NEws
Akman Tapped by Mayor
to Serve on D.C. HIV/AIDS
Commission
Jeffrey S. Akman, M.D. ’81, G.M.E. ’85, interim
vice provost for health affairs and dean of GW’s
School of Medicine and Health Sciences, was
appointed by Washington, D.C., Mayor Vincent
Gray to serve on the newly established Commission on HIV/AIDS. Akman is recognized as
an expert in the psychiatric care of gay, lesbian,
bisexual, and transgender individuals (GLBT ).
“Mayor Gray’s decision to establish this commission reflects a significant commitment by the
city to intensify its efforts to address the HIV/
AIDS epidemic that is affecting so many people
in the nation’s capital,” Akman said.
With an HIV/AIDS prevalence of more than
3 percent among its adult population, Washington, D.C., suffers from the highest infection
rate of any city in the United States and a rate
more than three times above the threshold for
what the Centers for Disease Control and Prevention considers a “severe epidemic.”
Akman is one of a handful of psychiatrists
who defined and developed the field of HIV/
AIDS psychiatry in the mid-1980s. He was the
principal investigator of a National Institutes of
Health grant to train health care professionals
in medical and mental health aspects of HIV/
AIDS, and has presented at numerous national
meetings on the subjects of HIV/AIDS neuropsychiatry and GLBT psychiatry. n

M.D., clinical professor of Psychiatry and Behavioral Sciences; and
Melvin Stern, M.D., clinical professor of Psychiatry and Behavioral
Sciences, into its select association. All five new members are also in
the 2011 class of GW emeriti faculty.
The Senior Society, chaired by Seymour Perlin, M.D., professor
emeritus of Psychiatry and Behavioral Sciences; Constance Battle,
M.D. ’67, adjunct professor of Prevention and Community Health; and
Stanley Marinoff, M.D., professor emeritus of Obstetrics and Gynecology, promotes continued intellectual, creative, and social engagement for GW medical emeriti, retiring/retired faculty, and local alumni
from SMHS who graduated in the 1970s or earlier.
Launched in the spring of 2010 with the motto, “You can’t retire from
what you are,” the society hosts a series of events that foster and preserve relationships among physicians, scientists, and scholars who are
transitioning into retirement from their faculty positions or local practices, but who wish to remain productive in their discipline. n
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Rachel F. Brem, M.D., F.A.C.R.

Signing on with
the Senior Society

Brem Welcomed as Fellow in the
American College of Radiology

GW’s School of Medicine and Health Sciences

Rachel F. Brem, M.D., F.A.C.R., director of Breast Imaging and In-

(SMHS) Senior Alumni, Faculty, and Emeriti So-

tervention, and vice chair, Department of Radiology at GW’s School

ciety recently welcomed Edward De Fabo, Ph.D.,

of Medicine and Health Sciences, was welcomed as a Fellow in the

research professor of Microbiology, Immunolo-

American College of Radiology (ACR) during the association’s 88th

gy, and Tropical Medicine; Willis A. McGill, M.D.,

ACR Annual Meeting and Chapter Leadership conference.

professor of Anesthesiology and Critical Care
Medicine and of Pediatrics; Frances Noonan,

Brem is among the just 10 percent of ACR members who achieve
this high honor, which is awarded to clinicians with a history of ser-

M.D., professor of Microbiology, Immunology,

vice to the ACR, as well as achievement in Radiology, teaching, or

and Tropical Medicine; Stephen Rosenblum,

research. n
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Griffith Receives
Award for
Contributions to
Psychiatry and Culture

pathways help maintain the balance
between specific, critical types of
neurons developed in the brain.
After presentations by graduate
SMHS students, the GW Cancer Institute hosted a panel discussion about
the future of neuroscience research
moderated by the institute’s Executive
Director Steven Patierno, Ph.D. n

James L. Griffith, M.D., professor of
Neurology, interim chair of Psychiatry
and Behavioral Science, and director
of the Psychiatry Residency Program
at GW’s School of Medicine and

Cawley Receives
Eugene A. Stead
Award of Achievement

Health Sciences (SMHS), received the
Creative Scholarship Award from the
Society for the Study of Psychiatry
and Culture (SSPC) at its annual
meeting, June 2–4. The award is

creative contribution to the field of

The Developing Brain
and Cancer

cultural psychiatry.

Just a few decades ago, the connec-

has made a recent, significant, and

“Learning how to treat patients

tion between neurobiology and cancer

within the family, community, and

biology was suspected, but unspoken.

cultural contexts of their lives is still

“Today it is one of the most robust

a frontier for American psychiatry. I

interfaces between basic neurosci-

am honored to be given the Creative

ence and clinical medicine,” said

Scholarship Award for my efforts,”

Anthony-Samuel LaMantia, Ph.D.,

said Griffith, who developed a model

professor of Pharmacology and Physi-

of psychiatric residency training that

ology in GW’s School of Medicine and

focuses on both culture and neurosci-

Health Sciences (SMHS) and founding

ence to prepare residents for practice

director of the GW Institute for Neuro-

in the multiethnic and international

science at the first annual Neurosci-

communities of Washington, D.C.

ence symposium, April 27.

Two SMHS Psychiatry residents

The symposium, titled, “The Devel-

were also recognized during the

oping Brain and Cancer,” featured

SSPC meeting. Yavar Moghimi, M.D.,

four leading researchers — including

a fourth-year resident and recipient

SMHS’s Sally Moody, Ph.D., professor

Wasserman Elected to
AOA Board

of the 2010 John Spiegel Fellowship,

of Anatomy and Regenerative Biology,

Alan G. Wasserman, M.D., Eugene

presented a documentary about how

and Vittorio Gallo, Ph.D., professor of

Meyer Professor, and chair, Department

long-term inmates in the Washing-

Neuroscience at SMHS and director

of Medicine and President, GW Medical

ton, D.C., prison system adjust to life

and Wolf-Pack Chair in Neurosci-

Faculty Associates, has been elected

outside prison following their release.

ence at the Center for Neuroscience

to the board of directors of Alpha

Brandon Kohrt, M.D., a third-year resi-

Research at Children’s National Med-

Omega Alpha as a councilor director.

dent, received the 2011 John Spiegel

ical Center. They highlighted advances

The board consists of members of the

Fellowship for his work with the Carter

in neuroscience that contribute to the

society elected by the board of direc-

Center to improve mental health care

understanding of the developing brain

tors based on recommendations from

in Liberia. n

and how cancer can compromise it.

the nominating committee and installed

Moody detailed the earliest stages
of nervous system development, and
Gallo discussed how certain signaling
30 GWUMC.EDU • F A L L 2 0 1 1

after election by the board.
Wasserman previously served as
an Alpha Omega Alpha councilor,

© the ISPot

given annually to an individual who

The American Academy of Physician
Assistants (AAPA) selected James
Cawley, P.A.-C., M.P.H, professor of
Physician Assistant Studies in GW’s
School of Medicine and Health Sciences (SMHS), to receive the Eugene
A. Stead Award of Achievement for his
pivotal role in moving the Physician
Assistant (P.A.) profession forward
through his work as a certified practitioner, educator, scholar, and leader.
Cawley is founder and director of
GW’s joint P.A./M.P.H. program, the
first of its type in the United States,
which trains individuals for careers
that bridge clinical practice and disease prevention. n

FaCulty NewS
helping to nominate local members, contribute to service
projects, and administer chapter activities. As a councilor
director, he will maintain his responsibilities as a councilor,
as well as assist in the decision-making process that will
lay the foundation for the future of the society. n

administrator and is poised to lead an already vibrant team
dedicated to caring for kids.”
A board committee launched a national search following
the retirement announcement by Edwin K. Zechman, after
17 years of leadership. n

Look Before You Tweet
New research conducted by Katherine Chretien, M.D.,
F.A.C.P., associate professor of Medicine at GW’s School of
Medicine and Health Sciences, reveals that although social
media has a potential positive role in medicine, greater
accountability and clear guidelines are needed, as some
physicians who are regular users of Twitter are disseminating unethical and unprofessional content. A research letter
titled, “Physicians on Twitter,” was included in the Feb. 9
edition of the Journal of the American Medical Association.
“This research helped us to identify how physicians are
using social media and has helped us gauge whether or
not there is need for greater accountability for physicians
who use social media,” said Chretien. “While the majority
of tweets were potentially helpful, the ethical breaches and
unprofessional content raised a red flag.”
The study, approved by the Washington, D.C., Veterans
Administration Medical Center, was initiated to review the
professionalism of self-identified physicians on Twitter
and how they use the social media tool. Over a one-month
span Chretien examined 5,156 tweets from 260 physicians
with 500 or more followers. She found that 3 percent of the
tweets could be categorized as “unprofessional,” meaning
that they included profanity, potential patient privacy
violations, sexually explicit material, or discriminatory
statements. n

Newman Named CEO
of Children’s National
Kurt Newman, professor of Surgery, and of Pediatrics, at
GW’s School of Medicine and Health Sciences, was named
president and chief executive officer for Children’s National

PhotograPhy by holger thoSS

Medical Center effective Sept. 1, 2011. Newman has been
at Children’s National for more than 25 years and most
recently served as the senior vice president of the Joseph
E. Robert Jr., Center for Surgical Care.
“Dr. Newman articulated an impressive vision to lead
Children’s National,” said James Lintott, chair of the Board
of Directors at Children’s National Medical Center. “He
is an accomplished physician, researcher, educator, and

Margaret Plack, P.T., Ed.D.

Margaret Plack, P.T., Ed.D., Receives
American Physical Therapy
Association’s Award
Margaret Plack, P.T., Ed.D., interim senior associate dean
for the Health Sciences Programs and associate professor
of Health Care Sciences at GW’s School of Medicine and
Health Sciences (SMHS), received the Award for Leadership in Education from the American Physical Therapy
Association (APTA). This award, which is the highest honor
conferred by the education section of APTA, is given to
individuals who have had a substantial impact on physical
therapy and physical therapy education through scholarship, teaching, administration, and service activities.
“There are few people in the country who have accomplished as much as Dr. Plack to advance our understanding of the importance of physical therapy and how it
can help improve the lives of patients, especially children,”
says Jeffrey S. Akman, M.D. ’81, G.M.E. ’85, interim vice
provost for Health Affairs and dean of SMHS.
Plack received her award during the education section
business meeting and reception at the combined sections
meeting of the APTA in February. n
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First-Year medical student Allison Hoff with Russell Libby, M.D. ’79.

Adopt a Doc
new scholaRship pRogRaM enables sMhs aluMni
to put a face and a naMe to donations

Allison Hoff had nearly exhausted her five minutes at an
Internet café when the e-mail arrived. “Congratulations!”
it read. “Based on your exemplary record, the Committee
on Admissions is pleased to offer you a School of Medicine
Scholarship … while in the Doctor of Medicine degree program at The George Washington University.”
“I was shocked,” says Hoff, who was attending a wedding
in Greece before moving from California to Washington,
D.C., to begin life as a GW medical student.
Hoff, a former Peace Corps volunteer, had never even
heard of — let alone applied for — the scholarship she
received. No one had. But with that e-mail, Hoff became the
first “Adopt a Doc” scholar in a new program through which
School of Medicine and Health Sciences (SMHS) alumni
can support an incoming medical student’s education with a
minimum gift of $20,000 over four years.
To whom did Hoff owe thanks for the generous surprise?
SMHS alumnus Russell Libby, M.D. ’79, a Virginia pediatrician who developed the fund in memory of his mother, Leona
Libby Feldman. Libby’s siblings and stepfather, and each of
their families, have since contributed to the fund.
“I wanted to create something that embodies who my
mother was in a concise and meaningful way,” says Libby,
a longtime donor to SMHS. “I feel good knowing that the
contribution has a name and a face and is someone for whom
I can potentially act as a mentor.”
Hoff and Libby met for the first time on Aug. 10. It was
the beginning of what is expected to be a special relationship
for both. “Being a physician has been a huge privilege,” says
Libby. “I am grateful for my roots at GW, and I feel it is my
duty to support those who come after me.” n
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The business-savvy side of Evelyn Y. Davis appreciates that
her physicians at The George Washington University Medical
Faculty Associates (MFA) work together to keep her healthy.
In order to show them just how much she appreciates them,
she and the Evelyn Y. Davis Foundation recently established
the Evelyn Y. Davis Fund with a gift of $100,000 to support
several MFA clinical departments.
Davis, who studied Business Administration at GW, considers herself the nation’s foremost activist-shareholder. She
owns stock in roughly 80 corporations and has been a vocal
participant at shareholder meetings across the country since
the 1960s. She is the founder and editor of Highlights and
Lowlights, a national financial newsletter featuring analysis
on key business issues such as corporate governance and executive compensation, which is distributed only to the CEOs of
national corporations. Davis is a regular guest on financial
news programs such as CNBC, Fox Business News, and
Comcast Newsmakers, and is frequently featured in many
national newspapers. She also has been an invited lecturer
at many universities and colleges, including Babson College,
Northwestern University’s Medill School of Journalism, the
Darden School of Business at the University of Virginia, and
Penn State’s School of Journalism.
Born in Amsterdam, the Netherlands (which, she jokes,
was “on the wrong side of the ocean, but the very right side of
the tracks”), Davis was a member of GW’s Class of 1951, the
same class as Jacqueline Bouvier Kennedy Onassis, and has
generously offered support to many areas of the University.
“Evelyn Y. Davis has always been very supportive,” says
Alan G. Wasserman, Eugene Meyer Professor, and chair
Department of Medicine, and president of the MFA. “Thanks
to her generosity, we will be able to advance our clinical care
programs and provide service to our patient community.”

Continued on page 34

Above from left, George Washington University President Steven Knapp,
Evelyn Y. Davis, and Medical Faculty Associates CEO Stephen Badger.
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Savvy Support from
Evelyn Y. Davis

CLAss NoTEs

1940s

1970s

Luther W. Brady, M.d. ’48,

richard L. aBBOtt, M.d. ’71, was named
the new president of the American
Academy of Ophthalmology on
Jan. 1, 2011. Abbott was most recently
a member of the academy’s Committee
of Secretaries and chair of the board of
Ophthalmic Mutual Insurance Company. He received the academy’s Lifetime
Achievement Award in 2006, and he
was elected into the Academia Ophthalmologica Internationalis in 2008.

Distinguished University Professor,
Department of Radiology Oncology,
Drexel University College of Medicine,
recently received the Philadelphia
County Medical Society’s Cristol Award
for enhancing the society’s educational,
scientific, and charitable goals. Brady
also received the Pennsylvania Medical
Society’s Distinguished Service Award.
Bernard OstrOW, M.d. ’48, retired
last year after many years of service
in the Department of Medicine at
GW’s School of Medicine and Health
Sciences.

1960s
FLOyd d. LOOp, M.d. ’62, G.M.e. ’68, joined
the board of directors for Management
Health Solutions, Inc. Loop has been
published more than 350 times and
has served on the editorial boards of
numerous health care publications.

received
the Franklin Norwood Rogers Award as
New Hampshire Retired Pediatrician of
the Year for 2010. He officially retired
in 2001, but stayed on as a consultant
in the developing field of pediatric
mental health care until 2003.
arthur siMinGtOn, M.d. ’68,

pauL rOth, M.d. ’76, chancellor of the
University of New Mexico (UNM)
Health Sciences Center and dean of the
UNM School of Medicine, will serve as
chair-elect for the Greater Albuquerque Chamber of Commerce Board of
Directors. He recently served as acting
president of UNM while President
David Schmidly recovered from surgery
to remove a small tumor.

1980s
MichaeL r. Marks, M.d. ’82, G.M.e. ’87,

was appointed vice president
of business development at Norwalk
Hospital in Connecticut. Marks will
be responsible for the hospital’s business development, occupational health
services, and marketing and communications.

M.B.a.,

MeLanie BOne, M.d., G.M.e. ’86, received
the Annual Women in Leadership Award
presented by the Executive Women of
the Palm Beaches, on May 2011, for her
hard work, passion, and success in
medicine.
WiLLiaM hiGGins, M.d. ’86, was named
the Medical Director of the Westchester
Medical Practice, in Yorktown Heights,
N.Y., where he will oversee the medical
operations of the group.
JeFFrey s. FischGrund, M.d. ’87, was
named one of the 100 Best Spine Surgeons and Specialists in America by
Becker’s Orthopedic and Spine Review. Fischgrund is a spine surgeon at
Beaumont Orthopaedic Center in Royal
Oak, Mich. He is a researcher on bone
morphogenic proteins and cervical disc
replacements. Fischgrund has served
as editor-in-chief of the Journal of the
American Academy of Orthopaedic
Surgeons since 2009.
MichaeL cLyde dOLL, p.a.-c. ’88, was
recently elected to serve a two-year term
as director-at-large for the American
Academy of Physician Assistant’s Board

continued on page 35

kassan inducted into alpha oMega alpha
stuart s. kassan, M.d. ’72, F.a.c.p., F.a.c.r., was inducted into
the Alpha Omega Alpha (AOA) Honor Medical Society’s Class
of 2011 in recognition of his dedication to the profession and
art of healing. As a member of the University Board of Trustees
and president of GW’s School of Medicine Alumni Association, Kassan was elected to the GW chapter by AOA members
representing students, faculty, and staff of the GW School of
Medicine and Health Sciences.
“It’s a tremendous honor to be recognized by peers, and
even more gratifying when that recognition comes from your
medical school alma mater,” said Kassan.
Kassan is an internationally known expert in the treatment
of Sjogren’s Syndrome, a complex rheumatic disease that typically affects multiple areas of the body. He has served as a clini-

cal professor of Medicine at the University of Colorado Health
Sciences Center since 1994.
Election to Alpha Omega Alpha is a lifelong honor signifying a lasting commitment to scholarship, leadership, professionalism, and service.
James Katz, M.D., professor of Medicine; David Diemert,
M.D., assistant professor of Microbiology, Immunology, and
Tropical Medicine; David Popiel, M.D., assistant clinical professor of Medicine; Howard Pryor, M.D., Surgery; and Jeannie Yu, M.D., assistant clinical professor of Medicine; were
also elected to GW’s AOA Class of 2010–11. Edward O’Neil
Jr., M.D. ’87, was elected as an alumnus member; and Peter
Moskovitz, M.D., clinical professor of Orthopaedic Surgery,
received the Volunteer Clinical Faculty Award.
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founding dean
haL B. JensOn, M.d. ’79, was selected from a pool of more than 60
applicants to become the founding dean of the Western Michigan University (WMU) School of
Medicine in spring 2011. Jenson
most recently served as a professor
of pediatrics and regional dean in
Springfield, Mass., at the Western
Campus of the Tufts University
School of Medicine in Boston. He
brings more than 30 years of experience as a physician and educator
to his new position.
“Dr. Jenson is the right choice to
lead the development of our medical school,” said WMU President
John M. Dunn. “He brings a strong
background in academic medicine,
medical education, and research.”

Residential Support

A home can offer shelter, safety, and a sense of belonging, but what if it could also
provide a path to self-discovery, or academic achievement, or advancements in
research? A generous gift from a former medical resident promises to help GW’s
School of Medicine and Health Sciences do just that by training future generations
of mental health professionals and helping them cope with the rigors of their profession. And it’s all thanks to a home.
Cynthia B. Stevens, M.D., G.M.E. ’89, and her husband, Charles W. Havens
IV, have created a fund to support psychotherapy and psychoanalytic training for
psychiatry residents at GW. Established through a bequest stemming from the sale
of their home in Lander, Wyo., the endowed fund will enable the Department of
Psychiatry and Behavioral Sciences to continue to attract skilled residents. The
fund will provide financial assistance to residents for personal psychotherapy — a
key component of comprehensive training in psychotherapy and a cornerstone of
psychoanalytic training.
Stevens, a board-certified psychiatrist and psychoanalyst, served as the chief
resident for outpatient services during her training at GW. Her clinical expertise
and interest lie with personality development, life change issues and stressors, and
anxiety and depressive disorders. She has been nationally recognized for her outstanding contributions to medical student and resident education. n

Creating a Meaningful Legacy
at GW is
If you have a retirement plan, it's easy to hel p
deserving students receive a world-class education
in the nation's capital. You can name the GW School
of Medicine and Health Sciences, Public Health and

Health Services , or Nursing as a beneficiary of some or

all of the funds that may remain in your IRA, 401(k),
or other plan after your lifetime. Just complete a new
beneficiary designation form that includes the Medical
Center and its Tax ID number (53-0196584) and
submit it to your plan administrator.
I

66

ve

A few of the benefits:

:,t i 1

As I enjoy retirement ,I continue

to reflect on GW-the place where it

all started .Through my estate planning,
I'm doing my part to ensure that the

dream I lived can be realized by others
in the future.

1)

-George Ellis, MD 156

'r. Ellis is supporting the GW Medical Center with a gift of
$100,000 through his IRA. His estate will receive a significant
tax deduction and GW will receive the designated portion of
his IRA tax-free.

34 GWUMC.EDU • F A L L 2 0 1 1

No change in lifestyle since your gift comes from
leftover funds.
Elimination of income and estate taxes that
otherwise would be due.
Flexibility to support the program of your choice.
We can answer your questions to help make it even
easier . Contact us today!
CALL: 202-994-7657

EMAIL:plannedgivingl @ gwu.edu

ONLINE:www.gwu.edu/give/plannedgiving

ClaSS NoteS
continued from page 33
of Directors. Doll is a clinically practicing physician assistant at the Geisinger
Medical Center in Danville, Penn.

1990s

k. danieL rieW, M.d., G.M.e. ’94, was
named one of the 100 Best Spine Surgeons and Specialists in America by
Becker’s Orthopedic and Spine Review. Riew is the chief of Washington
University School of Medicine’s surgical
spine center and director of the university’s Cervical Spine Institute. Among
his clinical and research interests, Riew
leads a group of experts at Washington
University treating the spinal injuries
of retired National Football League
players.
sOFia teFeri, M.d. ’97, F.a.a.p., has been
selected to participate in the 2010–11
class of the Claude Moore Physician
Leadership Institute, where she will
strengthen her leadership abilities and
gain the skills necessary to improve
health care in Virginia.

2000s

steven cunninGhaM, M.d. ’01, has
joined the staff at St. Agnes Hospital in

Baltimore, Md., and will specialize in
pancreatic and liver surgery. His recently
published bilingual book of children’s
poetry, Dinosaur Name Poems, was selected as winner of the 2009 Moonbeam
Children’s Book Award.
Lt. cMdr. peter seBeny, M.d. ’03, M.p.h.

’97, deputy head, clinical trials and
military studies, and research physician
in the United States Navy at the U.S.
Naval Medical Research Unit No. 3 in
Cairo, was awarded the medal “Knight
of National Order of June 27th” by
Djibouti Prime Minister His Excellency
Dileita Mohamed Dileita, for his efforts
in supporting capacity-building projects
with the Djibouti Ministry of Health.
JOhn yarBrOuGh, M.d. ’04, M.B.a.,

recently joined the medical staff at St.
Joseph’s Behavioral Health Center in
Stockton, Calif. He is a member of the
American Academy of Psychiatry and
Law, the American Academy of Child
and Adolescent Psychiatry, and the
American Psychiatric Association, and
Vice President of the Christian Medical
and Dental Association — Psychiatry
Section.

suMMeR of seRVice
Jack suMMer, G.M.e. ’81, received the Jane Lingo Alumni Outstanding Service
Award this spring in recognition of his long-standing commitment to educating
and mentoring GW medical students as well as providing desperately needed basic medical care for some of the world’s most underserved communities.
Summer leads teams of doctors as well as GW medical and public health students on a medical mission each spring to Thomonde, in Haiti’s impoverished
Central Plateau. The trips, in cooperation with the nonprofit organization Project
Medishare, offer students the opportunity to learn firsthand about the health
problems that plague Haiti, as they help provide basic health care to as many as
200 patients daily in health centers and mobile clinics, treating patients for both
acute and chronic diseases.
Summer completed his internship and residency training in Internal Medicine
at SMHS in 1981. He was a member of the GW Medical Faculty Associates, and
served as associate chair for clinical affairs in the Department of Health Care
Sciences until 1991. Summer currently practices in Washington, D.C., and also
serves as assistant clinical professor of Medicine at GW.
The Jane Lingo Alumni Outstanding Service Award was created in honor of
Jane Lingo, B.A. ’46, a dedicated alumna, staff member, and friend of GW. The
award is presented annually to faculty or staff members who are also George
Washington University alumni.

In Memoriam
Alumni
Bernard Katzen, a.a. ’34, M.d.
’38, the first of six family members
to attend GW and the first of four
Katzens to earn a degree from its
School of Medicine and Health Sciences (SMHS), passed away on Aug. 3,
2011.
Katzen served in World War II
and was a member of the invasion
forces that landed on Normandy
Beach June 6, 1944, according to
his Washington Post obituary. After
the war, he opened a family practice,
which he maintained for 49 years.
The Katzen family is deeply intertwined with the success of The GW
Cancer Institute (GWCI). Katzen, his
wife Mildred, A.A. ’45, B.A. ’46, his
late brother Cyrus, and his sister-inlaw Myrtle devoted considerable time
and attention to raising awareness
and support for GWCI’s mission,
particularly in the areas of general
oncology, radiation oncology, and
clinical care.
Katzen is survived by his wife; his
sister, Sally Cohen; his sons, Burton
and Harvey; three grandchildren; and
three great-grandchildren. Katzen’s
son Harvey and grandson Jason are
SMHS alumni, having earned their
M.D. degrees in ’75 and ’06, respectively. His nephew — Jay Katzen,
B.A. ’67, M.D. ’72 — is a GW
trustee.
Leonard C. aKMan, B.a. ’41,
M.D. ’43, passed away April 2, 2011.
After receiving his B.A. and M.D.
from GW, Akman performed his residency in Internal Medicine at Sinai
Hospital in Baltimore, Md. In 1946
he joined the United States Army
and served as a captain and medical
officer general, and later served as a

continued on page 36
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continued from page 35
U.S. merchant marine ship surgeon.
Following a cardiology fellowship at
Michael Reese Hospital and Medical
Center in Chicago, Akman returned
to Sinai Hospital, rising to the post of
chief of the Division of Cardiology.
Akman performed early research in
heart transplantation and was a pioneer in the use of cardiac catheterization and cineradiography. Akman was
a fellow of the American College of
Physicians, the American Heart Association, and the American College
of Cardiology, where he also served as
a governor. He is survived by a loving
family, including Jeffrey S. Akman,
M.D. ’81, interim vice provost for
Health Affairs and dean of the School
of Medicine and Health Sciences.

openly treat black patients. Feffer
chaired the medical advisory committee for the humanitarian aid
organization CARE and spent many
vacations during the 1960s and ’70s

training doctors in countries such as
Vietnam, Algeria, and Afghanistan.
He became an emeritus professor in
the mid-1980s.

In Memoriam
alumni

SeyMour l. AlterMAn, M.d. ’47

cArl r. lAHti, M.d. ’49

Hector l. AlVArez, b.S. ’99

JoHn M. lAnHAM, M.d.’62

len HugHeS AndruS, M.d. ’44

grAHAM Seldon leeS, b.S. ’88

rodney A. APPell, M.d., g.M.e. ’75

williAM w. loebMAn, M.d., g.M.e. ’79

VernA y. bArefoot, M.d. ’50

iVAn b. MAHAdy, M.d. ’67

rolf H. beSSin, M.d. ’64

rAlPH A. nernberg, b.S. ’50

wAyne bucHAnAn, cert ’95

frederick c. norcroSS, M.d. ’64

rAlPH J. cArbo Jr., M.d., g.M.e. ’50

SAMAntHA c. noSek, cert ’04

robert J. cereMSAk, M.d. ’60

rAyMond A. nueVe, cert ’00

conStAnce lArk cerny, b.S. ’80

MelVin orAM, M.d. ’53

robert n. coAle, M.d. ’43

SuzAnne M. PittS, M.d. ’60

MAurice c. coVey, M.d. ’56

cHArleS Plotkin, M.d. ’83

edward MCFarLand, M.d. ’41,
longtime friend and supporter of the
GW School of Medicine and Health
Sciences, died in March 2010 at the
age of 94. He served in World War II
as a flight surgeon and was awarded
two battle stars. He practiced medicine, obstetrics, and anesthesiology
from 1946 to 1979.

robert HerMAn crAbtree, M.d. ’54

MArgAret Ann rAgAn, cert ’96

woodrow f. croSby iii, cert ’03

irVing l. reif, M.d. ’36

cleM c. croSSlAnd Jr., M.d. ’46

guy A. ricHArdS, M.d. ’43

crAig MicHAel curtiS, cert ’04

PHylliS A. riggS, b.S. ’84

SHerMAn dAnielS, M.d., g.M.e. ’87

rAlPH b. roMney, M.d., g.M.e. ’49

Andrew P. dedick, M.d. ’43

MArk H. rozAnS, M.d. ’86

edwArd A. downS, M.d. ’54

robert gordon ScHAller, A.S. ’77

MicHAel edwArd drinkwAter, A.S. ’84

Victor ScHocken, M.d. ’56

Victor eScH, M.d. ’48

briAn gerArd ScnornAck, cert ’04

kAng fAn, M.d., g.M.e. ’69

Sol SHAz, M.d., g.M.e. ’69

Faculty

ricHArd lee fArMer, M.S. ’07

williAM H. SHeffield, M.d. ’61

donnie d. flint, b.S. ’82

cAtHerine r. SMitH, M.d. ’41

Milton A. foor, M.d. ’52

dAVid f. SMitH, M.d. ’58

SAMuel e. friSHMAn, b.S. ’53

eugene o. SteVenSon, M.d. ’60

MicHAel V. gAllAgHer, cert ’03

erin f. StewArt, M.d. ’02

cArMen gAnnon, M.d. ’76

dAniel J. Stone, M.d. ’43

PAMelA elizAbetH gelder, b.S. ’95

Anne M. tHoMPSon, M.d., g.M.e. ’71

Joel StePHen glASer, M.d., g.M.e. ’64

eMMet J. tHorPe, M.d. ’51

JoHn S. gleAton, cert ’04

Helen r. tHorSen, b.S. ’83

robert P. HAberkern, M.d., g.M.e. ’70

duSAn tiSMA, M.d., g.M.e. ’80

williAM H. HAll, M.d., g.M.e. ’79

loiS w. turnbAugH, M.d., g.M.e. ’71

AlAn c. HAMPSHire, M.d. ’59

ricHArd H. VelAJ, M.d., g.M.e. ’85

HerBert weintrauB, M.d.,
retired professor emeritus of Anesthesiology at GW Hospital, chair of the
operating room committee, chair of
the audit committee at the Medical
Faculty Associates, and chair of the
Graduate Education Planning Committee, died Feb. 24, 2011.
Henry FeFFer, M.d., a GW professor emeritus and prominent Washington, D.C., spine surgeon, died May
9, 2011. Feffer began practicing in
Washington in the late 1940s, and was
one of the first white physicians to

Percy J. HowArd, M.d. ’53
denniS r. JAckSon, b.S. ’90
dorotHy S. JAeger-lee, M.d. ’39
donAld A. JoHnSon, M.d. ’45
JoHn M. kennelly Jr., M.d. ’48
dAniel l. kirk, M.d. ’43
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in memorium

H. George Mandel, Ph.D., circa 1966

H. George Mandel, Ph.D.
June 6, 1924 – July 15, 2011
Everybody knew H. George Mandel, Ph.D., a faculty member
in GW’s School of Medicine and Health Sciences’ (SMHS)
Department of Pharmacology and Physiology for over 60
years. “Even when I went to the doctor, the doctor would ask,
‘How’s George?’” says Stella Moody, manager of departmental fiscal operations, who worked with Mandel for 17 years.
And, according to Moody, SMHS faculty, staff, and
students regularly used words such as kind and gentle to
describe Mandel, demonstrating that he wasn’t only wellknown — he was also well-loved. So it is an understatement
to say that Mandel, who — as far as records indicate — was
the longest-serving faculty member in SMHS history, will be
missed. Mandel passed away July 15, 2011, at age 87.
“It is difficult to exaggerate all that George Mandel did for
our department and our school,” wrote Vincent Chiappinelli,
Ph.D., interim associate dean of SMHS, associate vice provost
for health affairs, and chair of the department, upon hearing
the news of Mandel’s passing. “He joined GW in 1949 and
continued to give lectures, run the Caucus of Basic Biomedical
Science Chairs, and interview prospective students up until
a few years ago. He was loved by our students, faculty, and
staff. George was a gentle and sincere man who helped so
many people. He made a difference and will be missed.”
Mandel joined GW as a research associate and served as
a faculty member from 1950 to 2010, including 36 years as
department chair of the Department of Pharmacology prior

to its merger with Physiology. After stepping down as department chair in 1996, he continued to conduct research and
mentor young faculty members and medical students until
2010, when he became chair emeritus. In his letter recommending Mandel for emeritus status, Chiappinelli wrote, “Dr.
Mandel has made huge contributions to our school in many
areas, including leadership, teaching, research, and service.
In so many ways [he] exemplifies the ‘long and distinguished
service to the University’ that is described in the faculty code
when reviewing faculty members for emeritus status.”
Mandel’s love of teaching students was evident in his
participation in various activities, including Problem-Based
Learning, a series of small group conferences in which he discussed clinical problems with first- and second-year medical
students. He also organized a pharmacology discussion group
elective for senior medical students. One of his mentees, Julius
Axelrod, Ph.D., won the Nobel Prize in Physiology or Medicine in 1970 for work on a class of neurotransmitters.
Equally passionate about research and policy, Mandel
served as chair of the National Caucus of Basic Biomedical
Science Chairs from its founding in 1991 until 2008. The
caucus was a groundbreaking science policy group composed
of leaders of science associations and chairs of basic science
departments across the country, which promoted increased
funding for health research by educating political leaders
about its importance in improving the health of citizens.
Mandel received numerous awards throughout his career,
including the Distinguished Achievement Award from the
Washington Academy of Sciences in 1958; the Golden Apple
Teaching Award from the Student American Medical Association in 1969, 1985, and 1997; GW’s George Washington
Award in 1998; and the 2005 Distinguished Researcher Award
during GW’s 2005 Research Day. He became a member of the
Society of Distinguished Teachers at SMHS in 2001.
During World War II, Mandel worked for the U.S. military as an interrogator. As a German immigrant and chemist,
Mandel was recruited to “interrogate scientifically trained and
experienced German prisoners of war who had been sent to
this country by the military,” he told NPR in a 2008 interview
about Fort Hunt, the camp where he worked. All information
he and his colleagues gained — which included “discoveries in
microwaves, atomic and molecular studies, jets used in German
planes, and submarine technology” — was sent directly to the
Pentagon, according to a 2008 Washington Post article.
“Dr. Mandel’s contributions to GW and to this nation are
immeasurable,” said Jeffrey Akman, M.D., interim vice provost for Health Affairs and dean, SMHS. “He will be greatly
missed by his colleagues and by the thousands of SMHS
alumni he taught and mentored.” n
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Keeping the San Francisco
Giants Standing Tall
GW’s School of Medicine and Health Sciences
alumnus Ken Akizuki, M.D. ’93, parlayed a love
of baseball and a gift for medicine into a ticket
to the big leagues with the San Francisco Giants
as the team orthopedic surgeon.

